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Examining Early Interactions between Innate Airway Resident Immune Cells and Mtb-specific
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by
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Mycobacterium tuberculosis (Mtb) is the leading cause of death by an infectious agent in
the world today, infecting roughly one quarter of humans. Despite this, the mechanisms of early
pathogenesis and host protective innate immune responses remain poorly understood and
uncharacterized.
Lung resident Alveolar Macrophages (AMs) are the first host contact with Mtb bacilli
after inhalation and are thus key mediators of the early pulmonary immune response. AMs are
generally believed to reside entirely in the airway, but it was recently demonstrated that they
have the capacity to egress and enter into granulomas during pulmonary infection with
hypervirulent Mtb. Furthermore, we found that airway and non-airway AMs display distinct
transcriptional profiles that suggest differential effector functions based on compartmental
localization. The variety of effector function pathways expressed by non-airway AMs are
primarily mediated by NF-κB signaling and are indicative of an M1 activation phenotype, which
shifts the classic paradigm of AMs as permissive reservoirs for Mtb replication.
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In the current work, we examine the host and Mtb factors/signals that modulate these
compartmentally distinct AM effector functions and how these specific interactions determine
protective or detrimental outcomes for the host. We examine the various functions that AMs
contribute to the early immune response, focusing on migration from the airway, cellular
interactions with epithelial or recruited immune cells, Mtb phagocytosis and killing, and
inflammatory cytokine production. We also examine how specific Mtb cell wall lipid factors that
mediate drug resistance and virulence can modulate these AM effector functions, thus skewing
the host immune response.
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Chapter 1: Background and Introduction

1

1.1

Global Mtb burden as a critical public health threat

Mycobacterium tuberculosis (Mtb), the causative agent of pulmonary tuberculosis (TB)
infection, is one of the leading causes of death worldwide, infecting approximately one fourth of
the world’s human population and killing approximately 1.3 million people per year.1 While this
death toll is staggering, approximately 90-95% of infected people have latent disease (LTBI),
and remain mostly asymptomatic with no clinical hallmarks of disease. However, approximately
5-10% of the estimated 2 billion humans infected with Mtb will develop active TB (ATB) during
their lifetime. From 2000-2015, an estimated 33 million people died of TB with an estimated
total global healthcare cost of $617B USD ($41.1B USD per year on average) for treatment and
prevention per year.1-3 While Mtb is endemic in the human population of many poor and middle
income countries all over the world,1 the main reservoir of Mtb is actually domesticated livestock
and wild mammals.4,5 It is estimated that ~50 million domestic livestock are infected with Mtb,
costing the agriculture industry ~$3B USD per year.6 Mtb bacteria are transmitted by aerosol,
and the rapid dispersal of viable infectious bacilli from one mammalian host to multiple nearby
can readily establish infection across populations of most mammalian species. The establishment
of asymptomatic latent infection in the majority of infected hosts yields a vast pool of individuals
at high risk of becoming contagious or immunocompromised, and chronic exposure of infected
humans, livestock, or other mammals can heighten the risk of new infection or spontaneous
reactivation of LTBI individuals. All these factors contribute to the persistence of this ancient
disease, which has plagued modern Homo sapiens and our ancestors for over 9 millennia.7,8 With
all this in mind, it is no surprise that Mtb is regarded as the one of the most successful pathogens
2

in the world.
A significant contributor to the high global cost burden of Mtb treatment and prevention
stems from the difficulty of treatment, where the standard of care for drug susceptible Mtb strains
is a ~6 month course of a cocktail of three frontline antibiotics.9,10 Emergence of multiple drugresistant (MDR) and extensively drug-resistant (XDR) strains in 4% of new and 21% of recurrent
cases drives treatment regimens that can persist for >20 months.9,10
These shocking figures demonstrate how widespread and pertinent this threat is to global
public health and demonstrate the urgent need for research focused on addressing several gaps in
our knowledge of TB pathogenesis and treatment. Global research efforts should focus on
understanding Mtb pathogenesis, characterizing host immune correlates of protection,11,12
developing better diagnostic tools, prophylactic and therapeutic treatment strategies and creating
more effective vaccines. Mycobacterium bovis bacillus Calmette-Guérin (BCG) is currently the
only licensed vaccine against TB, which was developed for human use in 1921.13 While this
century-old approach to vaccination is effective at preventing lethality in infants and adolescents,
it is not effective at protecting against adult pulmonary ATB, highlighting a significant need for
new treatment strategies. Current research efforts are being made to discover novel antibiotics or
combinations of antibiotics that are less toxic and more effective than the current standard of
care. However, it is also likely that major strides in novel vaccine development will provide a
better option for global eradication of Mtb. Vaccination is a more attractive option because it is
generally less costly and can be performed once or over a short span of time while providing
long-term, broad protection with little risk of Mtb developing resistance.
Some of immune parameters that demarcate the differences between ATB and LTBI have
just recently been elucidated,11,12,14,15 which will provide insights to develop better diagnostic
3

and therapeutic tools. However, one of the greatest barriers to developing better vaccine
treatments for TB is our poor understanding of the early host response mechanisms that mediate
protective immunity against Mtb infection. Most current vaccine strategies in development are
focused on targeting the recruitment and effector functions of helper CD4+ T-cells16-20 and thus
driving the local formation of protective tertiary lymphoid follicles in the lung. These strategies
focus on adaptive immune responses, which are generally thought to be the key driver of
protection against Mtb. Unfortunately, pulmonary adaptive immune responses to Mtb are delayed
compared to other infections,21 due to delayed pulmonary dendritic cell (DC) migration and
antigen presentation to CD4+ T-cells in the lung draining lymph nodes (dLNs).22 Because of this
delay, adaptive immune responses often do not reach peak magnitude and efficaciousness until
over a month after exposure.23 As such, novel vaccine strategies should aim for hastening early
protective immune responses and/or preventing establishment of infection. These protective
early responses are likely initiated and driven by local pulmonary innate immune cells, and
understanding their interactions and functions is the focus of my dissertation research presented
here.
There is a growing body of evidence suggesting that early innate immune responses can
prevent the establishment of infection prior to the induction of adaptive immunity, providing an
attractive alternative to the current approach of controlling Mtb disease severity, spread, and
treatment after onset of symptoms of ATB. A meta-analysis of 41 studies of human cohorts
across the world found that approximately 50% of highly exposed household contacts of TB
patients remaining uninfected long term with no evidence of adaptive immune activation,24 and
other studies have highlighted a key but understudied role of early innate responses in prevention
of Mtb establishment and persistence in the lung. 25-28
4

Furthermore, almost 100 years ago it was accidentally demonstrated that humans have a
variable capacity for early clearance of Mtb by innate immunity alone.29,30 This terrible incident
demonstrated that human infants, which do not have robustly developed adaptive immune
repertoires, have variable capacity to prevent Mtb infection, thus providing evidence for
consequential interactions between Mtb and the innate immune system.
In 1929 and 1930 in the Lübeck General Hospital in Germany, 252 infants were orally
administered the standard 3 doses of the standard live BCG vaccine, which was established as
avirulent in humans and protective against lethal Mtb infection in infants and children.29 Due to a
tragic mistake, the laboratory stock of BCG used for the vaccination was accidentally
contaminated with live, virulent Mtb. This meant that all 252 infants were administered live
cultures of M bovis and Mtb, which led to TB disease related deaths of approximately one third
of these infants, with another third displaying moderate to severe TB disease and the remaining
third surprisingly showing mild symptoms or no TB disease.25,30
Together, these lines of evidence across many human cohorts demonstrate a critical role
for pulmonary innate responses in mediating early Mtb clearance. These findings further suggest
a differential ability of some individuals to entirely prevent the establishment of Mtb infection.25
My thesis research focuses on these innate immune interactions with Mtb, and how these
interactions can modulate short and long term disease outcomes.

1.2

Lung compartments play distinct roles during both homeostasis and infection

The lungs contain several distinct microenvironments, or compartments, that maintain
distinct homeostatic functions and ontologically distinct cell types.31,32 These compartments
5

provide specific immune niches which are associated with production of certain molecules and
signals at homeostasis, such as the production of surfactants and mucous in the airway, or the
expression of integrins in the vasculature. During infection-induced inflammation, the pulmonary
immune response is also tailored to the specific microenvironments associated with each
compartment, with inflammatory chemokines driving homing signals and migration of specific
cell types, which will be discussed in a later section. Additionally, distinct microenvironments of
each compartment can alter specific immune effector functions as cells home to the lungs from
circulation and migrate between compartments, thus suggesting plasticity of function dependent
on location/context.
The airway of the lung is the mucosal surface making direct contact with the outside
environment via inhalation and is associated with respiratory gas exchange and the physical
filtration and removal of inhaled particles and pathogens. Alveolar macrophages (AMs) and
myeloid DCs (mDCs) patrol the airway to phagocytose inhaled particles and pathogens, and
prevent unnecessary inflammatory responses to innocuous antigens.33 The various types of
alveolar and bronchial epithelial cells mediate gas exchange of O2 and CO2, as well as surfactant
and/or mucus production on their apical surface.34-36 Airway epithelial cells (AECs) express
Toll-like receptors (TLRs) on their apical surface and stimulation of these or other pattern
recognition receptors (PRRs) by exposure to inhaled pathogens or other insults induces airway
localized production of inflammatory cytokines and chemokines.34-36 These inflammatory
signals, as well as mucus, surfactants, and motile, non-stromal immune cells present in the
airway can be directly collected and examined ex vivo by bronchoalveolar lavage (BAL).37 At
steady state in most mammals, the majority of immune cells captured by BAL will be AMs and
mDCs, though acute inflammation drives recruitment of other cell types such as neutrophils38-42
6

and CD4+ T-cells42-45 to the airway.
The lung vasculature is the dedicated network of blood vessels mediating transport of
cells, nutrients, and gases to and from the lung. Expression of integrins and other
trafficking/extravasation molecules on the vasculature drives recruitment of cell types into the
lung tissue from circulation.46,47 Immune cells localized in the vasculature can easily be
determined by intravascular (i.v.) injection directly prior to harvest of lung tissue.48,49 I.v.
labeling determines the relative proportion of a given immune cell type in the vasculature
compared to the lung tissue, and thus can be used to examine migration of recruited myeloid and
lymphoid cell types into the lung.
The interstitium of the lung is the compartment between the airway epithelium and the
vasculature, broadly considered the “tissue” of the lung. The interstitial compartment is where
most immune cells, including recruited neutrophils, monocytes, and lymphocytes, migrate to in
response to inflammatory signals from the airway at the induction of the pulmonary immune
response.31,32 The interstitium is therefore the main site for formation of complex immune
structures such as granulomas and inducible bronchus associated lymphoid tissue (iBALT).50,51
AECs produce inflammatory signals to their basal surface in response to airway inflammation at
the apical surface, thus demonstrating differential interactions with airway immune cells as
compared to interstitial immune cells.34,35,52 Localization of immune cells within the interstitium
can generally be determined histologically or by stain exclusion as i.v. label negative using flow
cytometry. 53,54
The differential roles of the various compartments of the lung become even more
pronounced during inflammatory response or infection. Throughout this body of work, my
studies examine how the various functions of immune cells are altered based on their locations
7

and the implications of cellular location on pulmonary immunity during Mtb infection.

1.3

Mtb pathogenesis and early pulmonary immune responses

1.3.1

Initial exposure, Mtb sensing and phagocytic uptake
Mtb pathogenesis begins in the airway of the host with the inhalation of aerosolized water

droplets containing Mtb bacilli. These aerosolized Mtb are expelled from another infected host,
usually by coughing or sneezing.55-59 Mtb sensing in the airway relies on the expression of PRRs
by AMs and AECs, which drive several key processes that induce early inflammation and initiate
the immune response.
Recognition of inhaled pathogens and associated factors by epithelial cells leads to the
production of mucus, antimicrobial peptides, and surfactants that aid in neutralizing and
sequestering Mtb.35,36,52,60 Furthermore, this sensing and stimulation driven by Mtb lipids induces
local production of prostaglandins, bradykinins, and other inflammatory molecules that activate
afferent neuronal C-fibers in the lung mucosa to induce the aforementioned cough reflex58,61 in
most larger mammals. Interestingly, the cough reflex, which is a host attempt to dislodge and
expel the pathogen from the lung to prevent disease, actually helps drive aerosolization and
dissemination of the bacteria to other potential hosts.56,57,59 Considering that Mtb has specialized
its early pathogenesis and replication to take advantage of pro-inflammatory interactions
between airway AMs and AECs, the induction of cough can be viewed as an extremely effective
strategy to drive population persistence and spread of Mtb after establishment of disease.
Upon inhalation by the host, Mtb bacilli deposited in the lower airway are recognized and
phagocytosed by pulmonary AMs, which are tissue resident, fetal yolk sac derived, selfreplicating innate immune cells present in the airway of the mammalian lung.37,62,63 These
8

macrophages patrol the airway64-67 and are believed to be the initial contact and primary
reservoir of Mtb replication and persistence in the host.34,68-70
Phagocytic processes are induced by stimulation and binding of PRRs such as Mannose
receptor (MR),71,72 Dectin-1,73 or Complement Receptors (CRs)73-75 that are expressed on
AMs.76-78 Stimulation of these PRRs initiates a cascade of signaling events that drive actin
cytoskeletal rearrangement to surround and uptake the bacteria, thus driving the formation of an
early phagosome.77,79 This phagosome then “matures” via fusion events with several endosomes
that contain a variety of complexes designed to acidify the phagosome.
Effective “late” phagosome maturation includes addition of several components; the
vacuolar ATPase that pumps protons to acidify the compartment,79 the NADPH Oxidase and
inducible Nitric Oxide Synthase (iNOS)80-83 that produce reactive oxygen and nitrogen species
(ROS & RNS), and various other lipases, DNAses, and proteases. These components and their
products optimally function at low pH and make the acidic late phagosome a more hostile
environment for destruction of the pathogen.79,84-86 This late phagosome eventually fuses with a
lysosome to become the phagolysosome, which is the ultimate step of this microbicidal process.
The phagolysosome also interacts with other cellular organelles such as the Golgi apparatus,
endoplasmic reticulum (ER), and mitochondria,87,88 which all contribute to further activation of
the phagocyte. This phagocytic activation induces metabolic reprogramming,89-91 inflammatory
signaling,92 and antigen presentation.79,86,93 Interestingly, Mtb has developed a sophisticated
array of strategies for evading, impeding, or exploiting almost all of the aforementioned
processes, which I will outline in greater detail in a background section 1.4.
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1.3.2

Early AM effector functions dictate the overall pulmonary immune response
Despite being the primary reservoir for Mtb pathogenesis and persistence and the critical

initiator of the pulmonary immune response, characterizing the role of innate phagocytes like
AMs during infection has proven difficult. Historically, depletion of AMs in the context of lung
infection and inflammation models have yielded mixed results (Table 1).94-99 In some of these
studies, airway localized AMs and DCs were transiently depleted using intratracheal (i.t.) or
intranasal (i.n.) delivery of clodronate liposomes. In the context of pulmonary Mtb infection, this
depletion yielded improved disease outcomes as marked by improved T-cell priming,100
decreased pulmonary inflammation, gross lung damage, and total pathogen burden.96 It is
postulated that these improved outcomes may be due to AMs being an early replicative niche for
Mtb, and therefore removal of that reservoir impedes pathogenesis. Furthermore, improved
outcomes in this model can also be partially attributed to induction of macrophage apoptosis
instead of necrosis,101 thus yielding a more “beneficial” and less damaging form of cell death.
This clodronate depletion model likewise yielded improved outcomes during pulmonary
Pneumovirus (PMV) infection.102
In other studies, transient depletion was achieved with transgenic diphtheria toxin
receptor (DTR) models to target AMs and/or DCs (CD11c, CD169, etc.).98,99,103,104 In these
studies, AM/DC depletion yielded similarly mixed outcomes in a similar panel of lung infections
and inflammation models, where transient depletion of AMs/DCs was found to exacerbate
inflammation and pulmonary infection with Mtb, Francisella tularensis, Influenza and
Respiratory Syncytial Virus (RSV), 98,103-105 but yielded improved outcomes in the context of
allergic inflammation.99
These findings are in contrast to the previous studies and suggest that AMs may be
10

beneficial during pulmonary infection by helping control inflammation. These outcomes could
be attributed to the general anti-inflammatory functions of AMs, whereby production of IL-10
and “M2” effector functions aim to maintain homeostasis and decrease/resolve
inflammation.76,106-108 In this scenario, a lack of these anti-inflammatory signals would indeed
drive exacerbated and uncontrolled damaging inflammation.
The caveats for interpretation of these conflicting findings across models should be
mentioned. The models and techniques used involved differences in the timing, duration, and
mechanism of cellular depletion which yield distinct physiological consequences. Similarly, the
type of cell death achieved by the different methods influenced the type and severity of overall
inflammation induced, thus affecting “unintentional” tissue damage and pathology. All of these
factors together contribute to these mixed findings across models, making the positive or
negative contribution of airway AMs and their overall role in lung defense context dependent
and difficult to concisely ascertain. It is interesting to note that no studies to date have found
AMs/mDC depletion to have no consequential role in pulmonary defense against infection, thus
demonstrating how critical these cells are for the benefit of either the pathogen or the host.
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Table 1:Alveolar macrophage/pulmonary mDC depletion models yield mixed results in various infection and
inflammation contexts. Depending upon method and infectious/inflammatory model used, depletion of airway
macrophages drives divergent outcomes. Timing of depletion, though not mentioned here, may also be a significant
factor. No studies to date have found AM/mDC depletion to have no effect. PMV=Pneumovirus; RSV=Respiratory
Syncytial Virus

1.3.3

M1 vs M2 effector functions for AMs
The M1-M2 binary of macrophage activation and function is a useful convention for

determining suites of genes and general functional effector responses for macrophages.109 M1
profiles are associated with increased iNOS production, improved phagocytosis and microbicidal
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function, increased inflammatory cytokine production,110-112 and a metabolic shift towards
glycolysis.67,89,109 On the other hand, M2 activation is characterized by decreased iNOS
production and inhibited microbicidal function, improved nutrient availability for pathogens like
Mtb, decreased production of pro-inflammatory cytokines,110-112 and a metabolic shift to fatty
acid oxidation (FAO) that actually provides a hospitable environment for Mtb.67
AMs and interstitial macrophages (IMs) can be distinguished not only by their
compartmental locations within the lung, but also by their differential expression of lineage,
macrophage, and monocyte markers, such as CD11b, CD11c, Siglec-F, CD64 (FcɣRI), MerTK,
CX3CR1, CCR2, CD115 (CSF1R, M-CSFR), CD116 (CSF2R, GM-CSFR), and MHC-II.113-120
Generally, monocyte-derived67,120 IMs are recruited from the bone marrow to the lung and are
considered M1-like. Accumulation of monocytic precursors and IMs correlates with pulmonary
protection and IMs yield improved Mtb clearance in vitro.67,109
On the other hand, AMs are associated with M2 anti-inflammatory activation, and are
historically regarded as being permissive to Mtb replication and persistence.67,109,121,122 Contrary
to this idea, Mtb DNA but not live bacteria has been found within AMs from histologically
normal lung samples.26 This finding suggests that AMs may have the ability to directly or
indirectly clear infection,25,26 thus supporting a microbicidal M1 phenotype and the idea that
AMs may not always be permissive as previously thought.
Recent work has demonstrated that many factors can alter macrophage phenotype and
effector function, thus suggesting that the M1-M2 binary dogma should be redefined as more of
a spectrum of responses across various contexts.123,124 Mtb factors have the ability to alter the
metabolic profile of macrophages, thus shifting “energy states”, favored carbon sources, effector
functions, and cytokine production.89,125 M1 activation is generally viewed as “inflammatory and
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protective” and M2 activation is regarded as “anti-inflammatory and permissive” with regard to
pulmonary infection. However, the timing, context, location, and magnitude of these responses
determines the helpful or detrimental nature of the overall outcomes.20,51 My work and others
have also demonstrated that M1 vs M2 polarization can be affected by localization within the
lung,109,110,113,126 suggesting that cellular microenvironment also plays a key role in determining
effector functions.
M1 activation and the IL-1β-inflammasome pathway are critical for macrophage
mediated Mtb responses and induction of early inflammation,127 though this interaction has also
been shown to contribute to detrimental and damaging responses for the host. Mtb targets the
activation of the inflammasome via ESAT-6 to induce IL-1β and pyroptotic or necrotic cell
death.128-131 Mice genetically deficient in IL-1β production or responses are much more
susceptible to acute Mtb infection.132 Pharmacological or genetic inhibition of the inflammasome
during infection with either Mtb or Influenza induced decreased inflammatory responses as
expected,133,134 but also surprisingly drove protective immunity by decreasing pathogen
replication/persistence.83,135 Thus, it is hypothesized that macrophage inflammasome activation
may be used by Mtb to induce and exacerbate persistent inflammation and necrotic or pyroptotic
cell death,130,131,136 though it is not likely used as a mechanism of improved virulence.128,136,137
Interestingly, both M1 activation and the IL-1β-inflammasome pathway are negatively
regulated by the IκB kinase complex subunit 2 (Iκκ2, Iκκβ) of the NF-κB complex, which is a
major node for inflammatory signaling in most cell types. Using pharmacological inhibition138
and/or genetic models139,140 to decrease Iκκ2 functionality, it was demonstrated that Iκκ2
negatively regulates inflammatory responses by specifically antagonizing M1 activation, MHC-II
expression, and inflammatory Type 1 cytokine production. Furthermore, Iκκ2 inhibition
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surprisingly drove increased Mtb control in vitro, due to heightened apoptosis driven by
increased IL-1β and inflammasome activity, thus also leading to increased local cytokine
production, tissue damage, and inflammation.138 We have observed similar phenotypes involving
NF-κB associated genes and M1 functional responses in my work, which I will discuss in detail
in Aims 1 & 2.
Taken together, these prior findings suggest that AMs have an important yet controversial
role, whether positive or negative, in pulmonary innate immune responses to infection, including
TB. Our knowledge of these cell types and targeting techniques generally focus on their role
specifically in the airway, although both mDCs and AMs are known to migrate to the lung
draining lymph nodes to present antigen.22,141,142 However, migration of these cell types within
the lung tissue, including migration to the interstitium109,126 and homing to granulomas, was
previously unknown prior to my first published manuscript, and was the focus of Aim 1 of my
dissertation.113 Aim 2 of my thesis work expanded upon the known effector functions of AMs
during Mtb infection, and elucidated further NF-κB-mediated M1 functions and interactions that
drive the previously observed differences in the immune role of airway and non-airway AMs.

1.3.4

Early coordinated inflammatory signals
AMs are the first contact interaction between inhaled pathogens and the host, and as such

are poised to initiate and control most inflammatory responses to inhaled potential insults. In the
context of Mtb pathogenesis, this process begins when Mtb specific cell wall lipid factors are
recognized by surface expressed PRRs on macrophages and AECs. Macrophages independently
and by coordinated interactions with AECs34-36,60 induce and amplify the local production of
inflammatory cytokines and chemokines via aforementioned NF-κB and/or inflammasome
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activation.64,125,143 This inflammatory signaling cascade drives the initial “first wave” recruitment
of myeloid cells from the bone marrow to the site of infection.51,52,144,145 Coordinated and
amplified production of cytokines and chemokines is the key to the initial “tailoring” of the
inflammatory response, which dictates the primary innate immune cells recruited to the site of
infection, and then later, the type of helper T-cell response that is generated.146 The interactions
between Mtb, AMs, and AECs that recruit this primary wave of inflammatory myeloid immune
cells are the first and most consequential steps in modulating both short and long term immunity.
Furthermore, the magnitude and type of inflammatory response generated by these interactions
can determine disease severity and outcome.51,64 These central themes can be seen throughout
Aims 1-3, and for these reasons I have chosen to focus my thesis work on early immunity,
specifically AMs and their interactions with Mtb and AECs.
The early drivers and controllers of inflammation include cytokines such as granulocyte
colony stimulating factor (G-CSF) and IL-17, which coordinate neutrophil dominated Th17
responses,147-152 Type 1 interferons (T1-IFNs) that regulate macrophage antimicrobial
responses,153 as well as IL-6, TNF-α, and IL-1β, which are general inflammatory mediators that
also drive M1-macrophage activation and Th1 responses (Table 2).91,148,154-158 Both of these
types of responses have been demonstrated to be crucial for Mtb control, both separately and
coordinated.159,160 To balance these inflammatory signals, the anti-inflammatory mediator IL-10
is also crucial for preventing overt tissue damage induced by an overactive immune
response.161,162 Together, these soluble signals initially produced by AMs and AECs play distinct
and balancing roles in activating, recruiting, and controlling the short and long term immune
responses to Mtb.
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Table 2: Early cytokine drivers and controllers of inflammation. The types of early pro-inflammatory cytokines
induced during infection depend on a variety of factors, including the host cell of origin, the type of pathogen
associated molecular pattern (PAMP) recognized, and the type of PRR stimulated. The various combinations of
cytokines produced drive different suites of host responses tailored to specific classes of pathogens.

1.3.5

Chemokine signals mediate homing to the lung and compartmental migration
Organization of immune cells within the various lung compartments is driven by multiple

chemokine: receptor axes produced by AMs, AECs, and other inflammatory immune cells,
which have been exhaustively discussed in previous reviews on the subject.23,64,143 These axes
are evolutionarily conserved across species, and often have either competing or redundant roles
for guiding migration/organization within the various compartments of the lung, though most are
involved in general recruitment to the lung from the periphery or specific homing within
granulomas.
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While the focus of my dissertation work is on innate immunity, compartmental migration
has been observed and explored much more thoroughly in adaptive responses of CD4+ T-cells.
Sharp differences in effector functions are observed with differential lung localization in the
airway, parenchyma, or vasculature, suggesting cellular microenvironment plays a significant
role in determining effector function. It has been previously demonstrated that for helper CD4+
T-cells to exert protective effects during TB, they must have direct MHC-II-dependent contact
with Mtb infected macrophages in the lung. Thus CD4+ T-cell migration into the parenchyma is
required for protection.163 Furthermore, this migration phenotype correlates with differentiation
status, where less differentiated CD4+ T-cells express C-X-C Motif Chemokine Receptor 3
(CXCR3) and migrate from the vasculature into the lung parenchyma and control Mtb growth,
whereas terminally differentiated, CX3CR1+ CD4+ T-cells remain in the vasculature and fail to
exert a protective role.164-166 However, differentiation status may not be the most defining feature
that limits T-cell migration,167 suggesting other factors likely contribute to this phenotype.
Interestingly, CX3CR1 deficiency improved CD4+ T-cell migration into the lung, suggesting that
these chemokine signals are in competition and potentially antagonistic.168 Beyond T-cells,
CX3CR1 is also associated with pulmonary homing of innate immune cells,166,169 and mediates
airway migration of DCs, macrophages, and neutrophils in response to intratracheal infection or
intravenous vaccination with BCG.169
Interestingly, despite the strong phenotypes associated with this differential chemokine
receptor expression and localization, no single chemokine receptor or ligand knockout fully
abrogated pulmonary CD4+ T-cell responses to pulmonary infection.168 While CXCR3
deficiency did indeed significantly decrease T-cell homing to the lung, other chemokine
receptors such as C-C Chemokine Receptor Type 2 (CCR2, discussed below), CXCR5, and
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others also contribute to pulmonary migration. Consistently, knockouts of these other receptors
also yielded minor defects in pulmonary migration.
CXCR5 expression on lymphocytes and innate lymphoid cells (ILCs) mediates
migration/homing from uninvolved lung interstitium tissue into iBALT-containing granulomas
via CXCL13, and this B and T cell homing correlates with protection in pulmonary TB models
across species.170-173 iBALT containing granulomas are a distinct functional microenvironment
specific to the inflamed/infected lung, and these immune structures facilitate antigen
presentation, affinity maturation and clonal expansion of antigen specific lymphocytes.51
Another key driver of pulmonary interstitial migration and granuloma organization is
CCR2. CCR2 is a major contributing axis for the recruitment of myeloid and lymphoid cells
from the bone marrow to the inflamed lung for both Th1 and Th17 responses.174 Inflammatory
cytokines and chemokines, especially monocyte chemoattractant protein 1 (MCP-1, CCL2), the
main ligand for CCR2, are produced from early onset of infection to promote recruitment of
innate immune cells, contributing to the massive first wave of the TB immune response.64,143
Many key cell types in the lung express CCR2, with monocytes and neutrophils being the most
well-characterized.100,144,145 Immature CD4+ T-cells, as well as airway resident mDCs and AMs,
also express CCR2.113,174,175 Interestingly, despite the expression of CCR2 on many key cell
types, previous studies have found a limited role for CCR2 during pulmonary TB,100,174,176
suggesting this axis may be dispensable.143 Aim 1 of my dissertation research focused on reexamining the CCR2 axis in the context of Mtb strain specific immune responses. In the process,
we observed a previously unknown migratory function of AMs into granulomas and described a
novel technique for examining compartmental localization of immune cells.113,126 These studies
further observed that AM effector functions can be location/compartment specific,109,113,126 and
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will be further discussed in Aims 1 & 2.
Taken together, these findings demonstrate the presence of distinct compartmental
microenvironments in the lung both at steady state and during infection. These compartments
induce specific homing/migratory signals and effector functions for a variety of immune cells.
Furthermore, these studies observe significant, overlapping contributions and redundant function
for multiple chemokine receptors, which is likely a fail-safe mechanism employed by the host to
ensure this functionality. Contribution of multiple chemokine receptors to this critical
compartmental localization phenotype is likely not exclusive to CD4+ T-cells, and a similar
phenotype may be present in AMs and/or other innate immune cells, though my studies have not
yet covered that possibility.

1.3.6

Early adaptive immunity and the formation of granulomas
The initial influx of bone marrow derived myeloid cells, guided by the aforementioned

inflammatory cytokines and chemokines, marks the first major wave of the pulmonary immune
response to Mtb. As Mtb continues to replicate and persist in permissive phagocytes, DCs
migrate to the dLNs and present Mtb antigen to naive CD4+ helper T-cells.20-22,177,178 It was
previously demonstrated that the characteristic “delay” in the adaptive immune response to Mtb
involves these processes, and priming/activation of CD4+ T-cells in the mediastinal lymph node
is the limiting step. This “bottleneck” is at least partially dependent on type of antigen, antigen
availability, and the number of viable bacilli present in the lymph node.22,142 Furthermore, it was
shown that intratracheal (i.t.) administration of activated DCs can resolve this “bottleneck”
delay.21 This therapy drove a much quicker and larger Mtb specific adaptive immune response,
resulting in near sterilizing immunity at early time points post-infection. After DCs activate Mtb
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antigen specific CD4+ T-cells, these T-cells clonally expand and migrate back to the lung as the
second major wave of the pulmonary immune response, which leads to the formation of
granulomas and iBALT.179-181
While difficult to test experimentally, it is widely accepted that infected phagocytes,
likely AMs and DCs, are the “seeds” of new granulomas.179,182 It has been demonstrated that
heavily Mtb-infected phagocytes cannot control Mtb growth but continue to produce
inflammatory cytokines and chemokines, thus attracting more phagocytes to serve as permissive
reservoirs.183-185 Heavily Mtb-infected cells are less bioenergetically active,90,186 likely less
motile, and also induce caspase dependent necrosis.131 Taken together, these functions likely
drive a localized inflammatory focus and induce homing of immune cells to the area. This
nascent granuloma is at first composed mainly of monocytes, macrophages, and neutrophils, and
then later by the aforementioned secondary wave of T-cells. These granulomatous foci drive
further tissue remodeling and localized inflammatory responses that lead to even more drastic
changes over time.179
Granulomas are the hallmark immune structures associated with TB disease, and
depending on a variety of factors, can be either protective or non-protective.51,64 Protective
granulomas serve to contain Mtb for sequestration and killing and are generally dominated by
Th1 responses and M1 macrophages.113 These macrophages perform several roles in order to
effectively contain and sequester free bacilli and Mtb infected cells to prevent spread outside of
the area. Furthermore, protective granulomas are also demarcated by the presence of ectopic
tertiary lymphoid follicles called iBALT,23,50,173,187 which contain a local pool of antigen specific
lymphocytes that aid in pulmonary defense and secondary responses to later infection.
On the other hand, non-protective granulomas are generally dominated by a hypoxic core
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of neutrophils and M2 macrophages89 and a concentric ring or “cuff” of T-cells around the
outside which are unable to penetrate into the granuloma.172 Th17 responses, which are
coordinated by early epithelial cell signals that drive neutrophil recruitment, have been
demonstrated to be protective against Mtb infection.148,149,151,152,188 However, as discussed
previously, it is likely that an overabundance of neutrophils is what drives uncontrolled
inflammation and tissue damage, as the extrema of inflammatory responses are considered
pathological. This neutrophil-dominated core allows for Mtb replication, large scale cell death
and overt tissue damage.189,190 These processes drive lung-damaging hypoxia and eventual
necrotic decomposition of the core,189,191 which leads to structural breakdown of the entire
granuloma. This breakdown prevents protective cellular interactions and proper containment,
thus driving Mtb persistence, replication, and dissemination to other areas of the lung and spread
to other tissues.51,64 The persistence of long term infection, the establishment of latent infection,
and dissemination to other tissues are beyond the scope of this dissertation and will not be
discussed in this body of work.
Aims 2 & 3 of my dissertation research draw connections between the early innate
immune response and the development of aforementioned adaptive immune structures. The
critical yet largely overlooked role of early innate immune responses, specifically focusing on
interactions between macrophages, pulmonary epithelial cells, and Mtb cell wall virulence
factors, was the focus of my second published manuscript presented as Aim 3.192 My work
demonstrates that macrophage effector functions such as cell migration, cytokine production,
apoptosis, and Mtb killing indeed broadly affect later adaptive immune responses, namely
formation of protective granulomas and iBALT. These immune structures ultimately determine
the individual’s sustained systemic response to Mtb infection and influence overall disease
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severity and outcome, highlighting the importance of examining and targeting these early
interactions in my work.

1.4

Mtb specific factors that influence immune responses

1.4.1

Mtb cell wall/capsule structure and composition
Mycobacteriaceae family species are a subgroup of Corynebacterineae and classified as

Gram positive bacteria.193,194 Interestingly, the slow-growing pathogenic Mycobacteriaceae
family species such as tuberculosis, ulcerans, and leprae display characteristics of both Gram
positive and Gram negative bacteria,193,195-197 which is indicative of the relative complexity of
these species’ cell walls. Furthermore, these pathogenic species share ~60-80% genome
sequence homology,198,199 suggesting that the relative complexity of the cell wall is a conserved
pathogenic strategy across species. This cell wall complexity is a key driver of the various host
evasion and exploitation strategies available to Mtb that drive overall pathogenicity. Several
excellent reviews focusing on the structure and biochemistry of the Mtb cell wall and capsule
have been published, which I will briefly summarize. Please see Figure 1 of Guenin-Mace et al
2009, Figure 2 of Kalscheuer et al 2019, or Figure 5 of Bansal-Mutalik et al 2014 for schematic
images of the Mtb cell wall/capsule as discussed below.193,194,200
The cell wall of Mtb is mainly composed of lipids and polysaccharides195,196,200,201 (~3060% dry weight) and is organized into four layers:193,194,200,202 (1) the plasma membrane or inner
membrane, (2) the arabinogalactan-peptidoglycan complex (AGP), (3) the mycobacterial outer
membrane (MOM) which is linked covalently to the AGP via mycolic acids, and (4) the outer
capsule.
The inner membrane (layer #1) is an asymmetric bilayer mainly composed of
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phospholipids and membrane proteins, similar to other bacteria. The AGP (layer #2) is, as the
name suggests, mainly composed of arabinogalactan and peptidoglycan.203 The AGP anchors the
MOM (layer #3) through covalent bonds with mycolic acids.200 Mycolic acids are essential for
Mtb survival,204 and are critical for the structure and organization of the MOM that drives the
characteristic low permeability of the Mtb cell envelope. These properties make Mtb resistant to
many mechanisms of destruction or perturbation by a variety of host strategies,204,205 such as
defensins206 and complement,207,208 and also contribute to the difficulty in classifying Mtb as
Gram positive or Gram negative.196,209,210
The MOM (layer #3) is an asymmetric bilayer mainly composed of long chain fatty acids
on the inner leaflet, and a complex outer leaflet composed of glycolipids and lipoglycans,
including: trehalose mono- (TMM) and dimycolates (TDM), sulfoglycolipids (SGL),
phosphatidylinositol mannosides (PIMs), lipomannan (LM), and lipoarabinomannan (LAM).
The outer capsule (layer #4) is composed of loosely packed polysaccharides such as αglucan and small amounts of mannan and arabinomannan. There are also abundant lipid species
such as trehaloses (including diacyl (DATs) and sulpholipids (SLs)), phthiocerol
dimycocerosates (PDIMs), including phenolic glycolipids (PGLs), and also PIMs.193,200
Many of these lipid virulence factors, especially those of the MOM and outer capsule
layers, directly interact with the host and are critically involved in modulating the host cellular
immune response during Mtb infection. These factors target specific PRRs to drive or modulate
cellular entry into specific compartments, induce or abrogate cytokine/chemokine production, or
evade host intracellular mechanisms of phagocytosis, degradation, and/or antigen presentation.
Interestingly, most of these factors are biosynthesized by enzymes from a relatively small
suite of genes, suggesting convergence of many important biosynthetic pathways into a limited
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set of critical backbone processes needed for virulence and pathogenesis. A key biosynthetic
nexus that Mtb cell envelope lipid factors critically utilize for virulence is the polyketide
synthase (PKS, pks1-15 genes) family of enzymes, which are multifunctional enzymes present in
many bacterial families that are involved in the production of secondary metabolites called
polyketides.193,211 The slow growing pathogenic Mycobacteria such as tuberculosis, ulcerans,
and leprae all express PKS, suggesting that these pathogenic species have evolved to utilize
these enzymes and their lipid products for pathogenesis. The aforementioned lipid virulence
factors such as mycolic acids,212,213 DAT and PAT,214 DIM and PGL,144,145,214,215 and
sulfolipid216 are all products of PKS family enzymes, and will be discussed below. Importantly,
disrupting either pks genes themselves,144,145,217 or some of their specific lipid products,217-219
leads to abrogated virulence in vivo. However, it should be noted that diverse Mtb strains express
differing ratios of PKS-associated virulence lipids,74,220-222 and depending on background strain,
modulation of these genes or individual lipid factors yields divergent immune
responses.113,125,223-225
The mycobacterial membrane protein large (Mmpl) family is a group of genes that
encode inner membrane transporters for Mtb cell wall lipid factors. Some of these transporters,
such as Mmpl7, are well characterized with regards to function, target substrate, etc, while
others, such as Mmpl2, remain relatively unidentified. Mmpl7 is an inner membrane protein
responsible for transport of PDIM to the MOM.226-228 These proteins are critical for maintenance
of the Mtb cell wall via the transport of lipids between the inner and outer membranes. Indeed,
mutants of Mmpl genes yield virulence and growth defects in vivo.226,227
Of the Mtb lipid factors mentioned above, the contributions of the aforementioned DATs,
PDIMs, and PGLs in modulating host immune responses, phagocyte interactions, and
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macrophage effector functions will be discussed throughout all three aims of my work.

1.4.2

Interactions between Mtb Capsular/Outer Membrane lipids and Host Surface PRRs
As discussed previously, the main host cells targeted in early Mtb pathogenesis are

professional airway phagocytes such as AMs and DCs, but lung epithelial cells throughout the
airway tract are also heavily involved. These host cells express a variety of PRRs that recognize
pathogen associated molecular patterns (PAMPs) in order to properly respond to foreign
substances, allergens, viruses, and bacteria. PRRs on innate phagocytes are utilized by Mtb lipid
factors to mediate cell entry by phagocytosis, including several complement receptors, DCSIGN, mannose receptor (MR), and Fc receptors.200,229,230
Complement Receptor 3 (CR3) is a heterodimeric complex of integrins CD11b and CD18
and is expressed on innate phagocytes at varying levels. Capsular α-glucan and PGL lipid factors
of Mtb are recognized by CR3 to enhance uptake and mediate cellular entry,74,231-234 thus
contributing to the initial steps of Mtb pathogenesis. Depending on the cell type involved in
uptake by phagocytosis, the other CRs can also play a major role in phagocytosis.75,233,235
However, to date none of the CRs have been shown to directly contribute to the phagosomal
sorting and eventual intracellular fate of the ingested bacterium.
DC-SIGN (CD209) is a C-type lectin that is constitutively expressed on DCs and can be
induced on AMs.236,237 DC-SIGN recognizes both capsular α-glucan and LAM from the MOM to
also mediate phagocytosis,236-239 and has been implicated in dampening immune responses.240,241
LAM from the MOM, as well as arabinomannan and mannan from the capsule, are also
recognized by MR. This binding interaction is critically involved in cellular entry and several
other immune mechanisms to be discussed below.71,242
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Arabinomannan specific antibodies on opsonized Mtb can be bound by Fc receptors,243,244
thus demonstrating another mode of cellular entry if vaccination or previous exposure have
induced a previous adaptive immune response. Taken together, these studies have demonstrated
that Mtb utilizes a variety of capsular and MOM associated factors to target several phagocytic
PRRs for enhanced uptake that drives cellular entry into specific, beneficial compartments for
Mtb growth and persistence.
Mtb lipid virulence factors have also been shown to target other PRR receptors, such as
TLRs, NLRs, and lectin receptors, are involved in modulating host pro-inflammatory responses
and cytokine production. As with the aforementioned phagocytic receptors, the expression of
these PRRs is known to vary between different cell types,245 so Mtb virulence factors that target
specific TLRs often drive divergent responses across models. Many Mtb lipid factors have varied
and often competing roles in the induction or abrogation of inflammatory cytokine responses,
depending on factors such as targeted cell type, specific receptor binding and interactions,
intracellular compartment location, and Mtb background strain. Pro-inflammatory cytokine
production initiated by TLR-Mtb lipid interactions is generally driven by the key inflammatory
signaling pathways mentioned previously, namely the inflammasome and/or the NF-κB pathway.
Anti-inflammatory responses that dampen cytokine production are generally driven by increased
production of IL-10 or modulation of host cell metabolism. Below I will summarize the complex
cytokine responses to several of the key Mtb lipid factors I discuss throughout this document
(Table 3).
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Table 3: Mtb lipid factors modulate early immunity by manipulating PRR responses. Different immune cell types
in the lung display varying distributions of PRRs. Distinct Mtb lipid virulence factors are recognized by specific PRRs
individually or in combination. In turn, these PRRs drive specific pro- or anti-inflammatory responses of secreted
cytokines or intracellular molecules.

Beyond their previously mentioned roles in modulating phagocytosis, MOM and capsular
mannan species such as LAM, LM, and PIM are recognized by surface TLR2246,247 either in
isolation or in cooperation with β-glucan receptor Dectin-1.73 These interactions have been
shown to drive NF-κB mediated production of TNF-α, IL-6, and RANTES by macrophages in a
TLR2 and Dectin-1-dependent manner.73 Interestingly, it has been documented that these
mannan lipid species can also mediate inhibition of inflammatory responses by utilizing
interactions with other PRRs. ManLAM, through aforementioned interactions with MR and DCSIGN, directly inhibits production of Th1 cytokine IL-12 and TNF-α248-250 while LM inhibits
production of TNF-α, IL-12, and NO in a TLR2-independent manner.72,247 These inhibitory
effects are likely due to the competing contributions of multiple receptors and their associated
signaling. Additionally, the differential expression of these receptors on distinct cell types likely
contributes to these divergent responses. Furthermore, the decreased production of proinflammatory cytokines may also be due to the interactions of mannan species with DC-SIGN on
activated phagocytes, which can drive increased production of anti-inflammatory IL-10.240,241
Similar to mannans, Mtb outer capsule PGLs are recognized by TLR2/4231 and also
CR3,234 and have been demonstrated to either induce or inhibit NF-κB mediated proinflammatory cytokine responses, depending on context.113,223,225 In a zebrafish model using a
model of M. marinum, PGLs were shown to augment inflammatory cytokine and chemokine
production, namely CCL2, leading to recruitment of permissive CCR2+ monocytes that
enhanced Mtb persistence and growth.144,145
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PGLs are highly expressed by lineage 2 W-Beijing family strains of Mtb,225,251,252 which
are specifically associated with hypervirulence in humans and mammalian models.218,223,253
PGLs can directly activate human neutrophils in vitro,254 and infection with PGL-expressing WBeijing family member Mtb HN878 correlates with accumulation of hyper-inflammatory
monocytes and neutrophils in the mouse model.14,113,125,224 These findings suggest that PGL
utilization in virulence may be an important and conserved strategy across host species.
Mouse studies demonstrate that Mtb strain HN878 also drives heightened proinflammatory cytokine responses and sustained increased disease severity,113,125,223,253 marked by
specific upregulation of the CCR2-CCL2 axis in the lung. This heightened inflammatory
response was not observed in the commonly used Mtb strain H37Rv, as this strain lacks PGLs
due to a frame-shift mutation in the Mtb pks15-1 gene.210 This suggests that PGLs play an
important role in this hyperinflammatory phenotype. Interestingly, when using a similar pks15-1
mutant on the HN878 strain background, our lab and others have surprisingly observed
heightened virulence and pro-inflammatory responses when compared to wildtype HN878.113,225
Taken together, these findings suggest that the specific contribution of PGLs and/or the PKS
enzymes may be more complex than previously thought, and other lipid virulence factors are
likely involved and counter-regulated in this model.
In contrast to this aforementioned pro-inflammatory role, purified PGLs derived from
Mtb directly bind to and inhibit TLR2, thus abrogating NF-κB activation.231 Indeed, Mtb that
overexpressed PGLs inhibited production of TNF-α IL-6, and IL-12 in vitro in
macrophages.225,231 This divergent role compared to in vivo studies is likely due to as yet
unknown interactions between Mtb and multiple other cell types, such as epithelial cells and
DCs, suggesting that Mtb-macrophage interactions in isolation may not be representative of the
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overall immune response. Taken together from studies of mannans and PGLs, it has been
demonstrated that these Mtb lipids have differing effects across both Mtb and host backgrounds,
and have contrasting roles in modulating immunity, thus making their isolated definitive
contributions difficult to surmise.
Another Mtb outer capsule glycolipid involved in modulating host pro-inflammatory
responses is SL-1. Sulfolipids like SL-1 are recognized by the intracellular PRR Nuclear
Oligomerization Domain 2 (NOD2),255 which in activated phagocytes triggers Mtb neutralizing
autophagy processes and pro-inflammatory cytokine production mediated by NF-κB and the
inflammasome. Similar to the other lipids discussed, SL-1 both stimulates and suppresses the
production of cytokines and ROS in activated phagocytes in vitro,256-259 thus demonstrating the
context dependent variety of responses elicited by the same molecule as a theme.
On the organismal level, SL-1 has recently been shown to drive the cough reflex in
guinea pigs and humans, thus augmenting transmission events as a pathogenic strategy.56-58 The
cough reflex is caused by activation of nociceptive C-afferent neurons, which are stimulated by
the local production of prostaglandins, bradykinins, and other inflammatory molecules by
epithelial cells. These studies demonstrate that neurons and epithelial cells are both directly
targeted by SL-1.61 Interestingly, despite its involvement in a variety of pathogenic strategies,
SL-1 is not required for virulence of Mtb H37Rv in the murine model,260 though its contribution
to virulence functions in other background strains has not yet been assessed. These studies
further highlight that isolated interactions between Mtb lipid factors and individual cell types
must be taken in context of the gestalt of interactions, where in vivo lung responses may be quite
different than isolated cellular responses in vitro.
PDIMs and DATs, which are structurally similar to the aforementioned PGLs and SL-1,
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respectively, are another topic of focus in my work. These lipids, like PGLs and SL-1, have also
been shown to directly inhibit pro-inflammatory cytokine production through several direct and
indirect mechanisms. PDIMs are a non-glycosylated structural precursor of PGLs,261 and are
known to mask Mtb PAMPs,145 thus inhibiting PRR recognition and downstream cytokine
signaling. Furthermore, PDIM also directly inhibits production of TNF-α and IL-6, as a PDIM
deficient mutant Mtb strain was observed to drive increased production of these cytokines in
macrophages and DCs.260 DATs are non-sulfated trehalose species which are recognized by
Macrophage inducible C-type lectin (Mincle).262-264 DATs have been shown to inhibit production
of TNF-α, IL-12, and IL-6 production in stimulated or infected THP-1 cells,265 though Mincle is
likely not required for this function. Similarly, DATs have also been shown to inhibit T-cell
proliferation, thus leading to an overall decreased inflammatory response.266
These findings demonstrate the complexity of Mtb lipid interactions with the host and
suggest that the individual contributions to inflammation are often interconnected amongst
multiple lipid factors and host cell receptors in concert.

1.4.3

Mtb lipid factors and intracellular immune evasion strategies
Beyond stimulating and modulating inflammatory responses, Mtb has evolved a robust

tool set of strategies for evading host defense mechanisms after cellular entry, targeted at
persisting within professional phagocytes like AMs and DCs. As mentioned above, Mtb utilizes
OM associated lipid factors in conjunction with host PRRs to skew cellular entry away from
bactericidal phagosomes. Even after cellular entry, a host of the aforementioned lipid factors are
involved in impeding Mtb killing within phagosomes and establishing a permissive environment
within the host cell for Mtb growth. For example, PDIM, in cooperation with ESX-1,267
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contributes to phagosomal damage which leads to Mtb escape into the cytosol and eventual host
cell necrosis.268
Even if the bacterium is phagocytosed, Mtb factors such as manLAM269,270 and
TDM72,271 prevent phagosome-lysosome fusion, thus bypassing mycobactericidal functions in
macrophages.71,242 Within the phagosome, PDIM is also required for early Mtb defense272 by
resisting the microbicidal action of NO.260 Along with this, PIMs establish a permissive niche for
growth of Mtb within phagocytes by driving phagosome fusion with early endosomes, thus
delivering essential nutrients for Mtb survival.273 SL-1 is also implicated in several of these
evasion strategies. SL-1 contributes to the alteration of phagosome-lysosome fusion274-276 and
also functions to shut down the respiratory burst of infected phagocytes via inhibition of
mitochondrial oxidative phosphorylation277 and suppression of ROS.256-259
These early subversion mechanisms are critical to pathogenesis and serve to delay the
generation of Mtb specific helper CD4+ and killer CD8+ T-cells and the onset of adaptive
immunity. Beyond targeting short term persistence of phagocytes, Mtb also has a variety of
strategies for driving sustained responses and evading adaptive immunity. Mtb induces
downregulation of MHC-II molecules on phagocytes,278-282 and utilizes mycobacterial
lipoprotein to specifically inhibit AM expression of MHC-II and CD80,283 thus impairing antigen
presentation and associated T-cell priming.121,284 Many of these Mtb lipid factors are also
involved in the broader long-term host immune response, and have been demonstrated to skew
formation of immune structures such as granulomas and iBALT. 192,285,286
Despite these sophisticated mechanisms Mtb has to thwart, evade, and delay the host
immune response, approximately 50% of exposed individuals remain uninfected, and in most of
these there is no evidence of an adaptive response at all, suggesting a critical role for early innate
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immunity and mucosal responses in early defense and rapid pathogen clearance.24,25 This would
be the ideal goal for a host directed therapeutic or vaccine; to elicit a primed innate response that
clears the pathogen quickly without the need to wait for adaptive immunity.287 Along these lines,
my research efforts have focused on understanding early innate immunity, specifically how Mtb
modulates inflammatory responses in airway phagocytes and epithelial cells to induce stark long
lasting effects that skew granuloma and iBALT formation, and overall disease outcome.
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Chapter 2: Identifying the critical role of
CCR2+ Alveolar Macrophages in protective
immunity during pulmonary Mtb infection
This chapter is excerpted from the following manuscript:
Dunlap et al. A novel role for CCR2 during infection with hypervirulent Mycobacterium
tuberculosis. Nature Muc Immunol. (2018) PMID: 30115997
Please refer to the above publication and/or attached appendix for supplemental data referenced
in this chapter
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2.1

Introduction
A major chemokine axis that recruits innate immune cells to the lungs is CCR2. CCR2−/−

mice aerosol-infected with Euro-American lineage 4 Mtb strains showed defective accumulation
of mDCs and macrophage/monocyte populations in the Mtb-infected lung, with coincident
delayed T cell responses.100,176 Despite decreased innate cellular recruitment, CCR2−/− mice were
surprisingly not more susceptible to Mtb infection,174,176 propagating the idea that the CCR2 axis
is dispensable for protective immunity to infection with Mtb.143
A major ligand for CCR2 is MCP-1 (CCL2), along with the ligands CCL7 and CCL12. In
human populations, meta-analysis of the identified −2518 A/G single nucleotide polymorphism
(SNP) in the promoter region of the CCL2 gene show significantly elevated risk for pulmonary
TB.288 Recent studies have highlighted differences in cytokine induction and immune
requirements for Mtb control to be dependent on the infecting Mtb strain.224,225,253,289 Studies
using the zebrafish granuloma model have described that M. marinum expressing virulence
factors such as PGLs drive increased expression of CCL2, and mediate recruitment of CCR2+
permissive monocytes to promote pathogenesis.144,145 Thus, murine studies suggest a dispensable
role for CCR2, zebrafish and M. marinum infection models suggest a pathological role for
CCR2, while human studies propose a critical but as yet undefined role for the ligand, CCL2.
AMs are tissue-resident phagocytes localized to the airway and are believed to be the first
contact and primary reservoir for replication of Mtb following inhalation of the bacteria.65,66
During acute Mtb infection, AMs can exacerbate spreading of bacteria and formation of necrotic
granulomas.65 However, despite the consensus that AMs are the first innate cells that interact
with Mtb, not much is known about how AMs participate to mediate control of Mtb infection.
In the current work, we show that AMs are amongst the earliest infected cells upon
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exposure to W-Beijing family Mtb strain HN878, they accumulate in the airways and express
CCR2. During disease progression, we demonstrate that AMs exit the airways and localize
within the TB granulomas. Importantly, following Mtb HN878 infection, sorted non-airway AMs
highly express genes belonging to classical macrophage activation, when compared to airway
AMs that express a unique transcriptional signature. Depletion of CCR2-expressing cells,
specifically at the timing of CCL2 induction and AM egress from the airways, resulted in
increased susceptibility to Mtb infection, with the accumulation of neutrophils and loss of Mtb
control. Additionally, we provide new evidence that mutant HN878 lacking PGL expression
surprisingly resulted in increased susceptibility, even in CCR2−/− mice.
In this study and another contemporary work, our lab and others developed a technique
for examining airway localization of immune cells.113,126 I.t. instillation49 of fluorophore
conjugated antibody to live mice prior to lung harvest allows for “airway labeling” of immune
cells by flow cytometry, giving us the ability to validate BAL techniques and importantly
determine the relative proportion of a given immune cell type present in the airway vs the lung
tissue (see supplementary data from Aim 1 manuscript113 for robust validation of this technique).
We determined that both populations of airway and non-airway cells were indeed bonafide,
tissue resident AMs, not replenishing monocyte-derived cells adopting an “AM-like” niche in the
airway.117,118,290 This novel technique is a critical component of the findings presented in Aim 1
and Aim 2 of my work, and helped determine a previously unknown migratory function of AMs
out of the airway and into granulomas. Localization of immune cells within the interstitium can
now be determined by exclusion of the i.t. and i.v. techniques mentioned, where airway and/or
vascular label “double negative” cells can be quantified as interstitial.
We show that migration out of the airway is guided by Mtb-strain specific upregulation of
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CCR2 on AMs and CCL2 expressed within and around Mtb granulomas at early time points.113
While we found the utility of the CCR2 axis to be Mtb strain dependent, specifically driven by
hypervirulent Mtb HN878 infection. The overall migration phenotype out of the airway was also
independently confirmed by another group using a different strain of Mtb, and involved IL-1β
and the inflammasome.126 In other separate studies, infected macrophages localized in the
interstitium or granulomas were observed to be more M1-like and infected airway macrophages
were observed to be more M2-like,109,110 thus validating our findings and demonstrating that
compartmental location can dictate differential macrophage responses in the context of the same
pathogen.
Together, our data provide novel evidence for a protective role for CCR2 in mediating
AM localization and immunity against emerging Mtb infections. Furthermore, this work
demonstrates an effective and novel protocol for examining airway and non-airway cells, and
defines a novel function for AMs in pulmonary defense.
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2.2

Results

2.2.1 CCR2 is required for AM accumulation and protective granuloma formation following
infection with emerging W-Beijing Mtb
Published studies thus far have shown a redundant role for CCR2 in Mtb infection,
specifically using Euro-American lineage 4 strains such as H37Rv and Erdman.100,176 These
studies have documented either negligible100 or small291 increases in Mtb burden in CCR2−/−
mice, unless CCR2−/− mice were infected with high doses of Mtb administered
intravenously.174,291 Our data confirms these findings as CCR2−/− mice showed similar lung Mtb
burden when compared with C57BL/6J (B6) mice following infection with Mtb H37Rv (H37Rv)
(Figure 1A). Additionally, CCR2−/− mice only showed a small increase in lung burden when
infected with another Euro-American lineage 4 clinical Mtb strain, CDC1551 (Figure 1B).
Infection with neither H37Rv nor CDC1551 resulted in increased dissemination to the spleen in
CCR2−/− infected mice (Figure 1A,B). In addition, infection with an Indo-Oceanic lineage1
clinical Mtb strain, T17x,292 also resulted in a small increase in lung and spleen Mtb burden in
CCR2−/− mice, when compared to B6 infected mice (Figure 1C). In sharp contrast, when
infected with lineage 2 Mtb HN878 (HN878), CCR2−/− mice showed significantly increased Mtb
burden at early days post infection (d.p.i.) which was also maintained during chronic infection
(Figure 1D). Indeed, CCR2−/− HN878-infected mice also exhibited increased dissemination to
the spleen, when compared to HN878-infected B6 mice (Figure 1D). Severe susceptibility with
increased lung and spleen Mtb burden was also observed when CCR2−/− mice were infected with
a pyrazinamide-resistant lineage 2 Mtb clinical strain, HN563 (Figure 1E). These results
together show a previously undocumented susceptibility of CCR2−/− mice to Mtb infection,
projecting a protective role for CCR2 in virulent, emerging W-Beijing Mtb infections.
To delineate the cellular mechanisms by which CCR2 mediates protective immunity
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against HN878 infection, we determined myeloid cell recruitment to the lungs of infected B6 and
CCR2−/− Mtb-infected mice (Supplementary Figure 1 - gating strategy by flow cytometry,
Appendix). Following H37Rv infection, we observed a trend towards decreased accumulation of
monocytes, AMs, recruited macrophages (RMs), mDCs, and neutrophils in the lungs of CCR2−/−
H37Rv-infected mice when compared to B6 H37Rv-infected mice (Supplementary Figure 2AE, Appendix) confirming previous findings.100,174,293 CCR2−/− mice also exhibited lower
numbers of RMs, mDCs, and monocytes in the uninfected lungs (Figure 1F, day 0). Upon
infection with HN878, CCR2−/− mice showed significantly decreased early AM and RM
accumulation and maintained a small reduction in monocyte accumulation, when compared with
B6 HN878-infected lungs (Figure 1F). Although mDC numbers were lower in uninfected lungs
of CCR2−/− mice, there were no significant changes in mDC numbers in CCR2−/− HN878infected mice when compared to B6 HN878-infected mice (Figure 1F). Also, the accumulation
of activated lung IFN-γ-producing CD4+ T-cells was comparable between B6 and CCR2−/− mice
infected with either H37Rv or HN878 (Supplementary Figure 1F-H, Appendix). These results
demonstrate that early macrophage accumulation and protective immunity are dependent on
CCR2 expression during HN878 infection, but that this requirement is dispensable for H37Rv
infection.
The decreased early accumulation of macrophage populations in CCR2−/− HN878infected mice coincided with significantly increased early accumulation of neutrophils, which
was maintained during chronic infection (Figure 1F). Incidentally, neutrophil accumulation is
associated with failed immunity to Mtb infection and neutrophils are the predominant infected
myeloid cell type.189,294-296 In support of this, we observed increased fibrosis and formation of
necrotic granulomas in lungs of HN878-infected CCR2−/− mice, when compared with lungs of
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B6 HN878-infected mice (Figure 1G,H). Expression of mRNA for tissue remodeling markers
such as Arginase-1 (Arg1), transforming growth factor (Tgfb1) and tumor necrosis factor alpha
(Tnfα) were also increased in CCR2−/− HN878-infected lungs (Figure 1I). Additionally, fewer
granulomas were found in CCR2−/− HN878-infected lungs, when compared with well-formed
granulomas present in B6 HN878-infected lungs (Figure 1J,K). Finally, although there was
decreased accumulation of AMs in CCR2−/− HN878-infected lungs (Figure 1F), more CD11c+
macrophages were infected with Mtb within granulomas of CCR2−/− mice, when compared to the
AMs in granulomas from B6 mice (Figure 1L). Together, these data imply that the CCR2 axis is
required for formation of protective granulomas during TB. In the absence of CCR2, there are
fewer macrophages and fewer protective granulomas formed, instead resulting in an influx of
neutrophils and development of necrotic granulomas that do not effectively control Mtb thus
leading to increased susceptibility.
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Figure 1: CCR2−/− mice show increased susceptibility to low dose aerosol HN878 infection. B6 and CCR2−/− mice
were aerosol-infected with ~100 CFU of (A) H37Rv, (B) CDC1551, (C) T17x, (D) HN878, or (E) HN563. Bacterial
burden in the lung and spleen was determined by plating (A-C and E) at 30 d.p.i. or (D) at different d.p.i. (F) Lung
myeloid cell populations were enumerated in B6 and CCR2 −/− HN878-infected mice using flow cytometry at
indicated d.p.i. (G-K) Pulmonary histology was assessed on FFPE lung sections from 30, 60 and 100 d.p.i samples
stained with (G) Trichrome staining or (J) H&E staining. (H) Inflammatory area expressing collagen was quantified
using Visiomorph image processing software to determine lung fibrosis (I) RNA was extracted from B6 and
CCR2−/− HN878-infected lungs and relative mRNA expression of specific genes was determined by qRTPCR. Gapdh was used as internal control. (K) Inflammation was quantified using the morphometric tool of the Zeiss
Axioplan microscope to determine the total number of granulomas per lobe. (L) The total number of
CD11c+ Mtb containing cells per 200X was determined by counting in FFPE lung sections of B6 and CCR2−/− mice.
AMs=Alveolar Macrophages, RMs=Recruited Macrophages, Monos=Monocytes, mDCs=Myeloid Dendritic Cells,
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Neuts=Neutrophils. n=5, (A-E) Student’s t-test between B6 and CCR2−/−, (F) 2-way ANOVA with Bonferroni’s posttest. (H-L) Student’s t-test was used to determine differences per time point.

2.2.2 AMs are preferentially infected with Mtb HN878 and require lung epithelial signaling for
accumulation upon infection
To delineate the unique requirement for CCR2 expression during HN878 infection, we
used H37Rv-GFP and HN878–GFP Mtb reporter strains and addressed if they similarly infect
myeloid cell populations, and if Mtb infection modulated CCR2 expression on myeloid cells.
Following in vivo infection with Mtb-GFP reporter strains, AMs more significantly uptake
HN878 than H37Rv, suggesting a preferential localization of Mtb HN878 within AMs (Figure
2A,B). Several lung myeloid subsets expressed CCR2 in H37Rv- and HN878-infected mice,
including AMs and RMs, monocytes, neutrophils, and mDCs (Figure 2C-E). Overall,
significantly higher numbers of AMs, monocytes, and neutrophils expressing CCR2 were found
in the lungs of HN878-infected mice, when compared to H37Rv-infected mice and uninfected
mice (Figure 2C-E). Following H37Rv infection, the RM population predominantly expressed
CCR2 when compared to expression levels in uninfected mice (Figure 2D). In contrast, during
HN878 infection, the predominant myeloid cell type expressing CCR2 was the AM population
(Figure 2D). Furthermore, we observed significantly increased CCR2 expression on AMs on a
per cell basis during HN878 infection, when compared with AMs during H37Rv infection
(Figure 2F). Thus, our data suggest that AMs preferentially uptake HN878 and specifically
upregulate the expression of CCR2.
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Figure 2: AMs are preferentially infected with HN878 and CCR2 expression on AMs is Mtb strain dependent.
(A) The flow cytometry gating strategy for myeloid populations. Briefly, AMs were defined as CD11b−CD11c+Siglec
F+ cells. mDCs were defined as CD11b+CD11c+ cells. Neutrophils were defined as CD11b+CD11c−Gr-1hi cells,
monocytes were defined as CD11b+CD11c−Gr-1lo cells, and recruited macrophages were defined as
CD11b+CD11c−Gr-1− cells. Mtb-GFP+ cells were gated from individual subsets. (B) B6 mice were aerosol-infected
with ~100 CFU of H37Rv-GFP or HN878-GFP and myeloid cell subsets infected with Mtb-GFP were determined by
flow cytometry on 30 d.p.i (n=5). (C,D) B6 mice (n=5) were infected with aerosolized H37Rv or HN878 and the total
number (C) and percentage (D) of CCR2+ myeloid lung cell populations were determined by flow cytometry and
compared to uninfected controls. (E) Representative histograms of each subset displaying CCR2 expression by
antibody staining compared to CCR2−/−. (F) Mean fluorescence intensity (MFI) of CCR2 expression on myeloid
populations was normalized relative to MFI of unstained, uninfected controls. Un.=uninfected, AMs=Alveolar
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Macrophages, Monos=Monocytes, RMs=Recruited Macrophages, Neuts=Neutrophils, mDCs=Myeloid Dendritic
Cells. (A-D) 2-Way ANOVA with Bonferroni post-test was used. (F) Student’s t-test.

To further elucidate the Mtb strain specific requirement for the CCR2 axis, we next
determined the expression of CCR2 ligands in H37Rv- and HN878-infected lungs. Early
expression of mRNA for Ccl2, Ccl7 and Ccl12 was significantly higher in HN878-infected
lungs, when compared to levels in H37Rv-infected lungs (Figure 3A). Additionally, CCL2−/−
mice infected with Mtb HN878 exhibited increased Mtb bacterial burden (Supplementary
Figure 3a, Appendix). However, since CCL2−/− mice did not fully reflect the heightened
susceptibility of the CCR2−/− mice to HN878 infection, other ligands such as CCL7 and CCL12
may mediate CCR2 driven protection during Mtb HN878 infection. Given the relevance of CCL2
in human disease,288,297 we chose to focus on CCL2 production in subsequent experiments. To
determine the main cellular sources of CCL2 upon infection, we assessed CCL2 levels in
supernatants of lung epithelial cells, DCs, and macrophages after in vitro infection with either
H37Rv or HN878. We observed that CCL2 production was significantly higher upon infection
with HN878 in epithelial cells and DCs (Figure 3B). In contrast, in macrophages as previously
shown,225 HN878 infection resulted in decreased CCL2 production when compared to H37Rv
infection (Figure 3B).
Epithelial cells induced CCL2 in response to infection with HN878, thus we
hypothesized that epithelial cell signaling may be involved in chemokine induction and
coordinate the localization or myeloid cells, including AMs to form granulomas. Thus, we
utilized the Iκκ2fl/fl Sftpc-cre mice,298 which lack canonical Iκκ2 and NF-κB signaling in Sftpcexpressing cells, mainly lung epithelial cells.299 Upon infection of Iκκ2fl/fl Sftpc-cre mice with
Mtb HN878, we observed decreased AM (Figure 3C) and neutrophil (Figure 3D) accumulation
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in HN878-infected lungs, without any changes in RM accumulation (Figure 3E) when compared
to myeloid cell accumulation in infected littermate controls. Associated with decreased AM
accumulation, Iκκ2fl/fl Sftpc-cre HN878-infected mice were more susceptible and exhibited
increased lung Mtb CFU at 30 d.p.i. (Figure 3F). We found that total protein levels of C-Cchemokines such as CCL2 and CCL3, and CXC-chemokines such as CXCL2 were not different
in lung homogenates of Iκκ2fl/fl Sftpc-cre mice, compared to littermate controls (Supplementary
Figure 3b, Appendix). However, we specifically found that lungs of Iκκ2fl/fl Sftpc-cre mice
exhibited fewer E-cadherin expressing epithelial cells producing CCL2 protein, when compared
to littermate controls (Figure 3G). The protein levels of CXCL1, a neutrophil attracting
chemokine, were reduced in total lung homogenates of Iκκ2fl/fl Sftpc-cre mice (Supplementary
Figure 3b, Appendix), likely resulting in the decreased neutrophil recruitment observed in
infected mice (Figure 3D). These findings suggest that early epithelial signaling has a role in
coordinating the accumulation of myeloid cells, specifically AMs and neutrophils, to the lungs
during infection.
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Figure 3: Increased early CCR2 ligand expression is induced in the lung following HN878 infection. (A) RTPCR analysis was performed at 21 and 30 d.p.i. to determine mRNA expression for Ccl2,Ccl7, and Ccl12 in lungs of
H37Rv- or HN878-infected mice (n=5 per group, per time point). (B) C10 epithelia, BMDCs, and BMDMs were
cultured and infected with indicated Mtb strains at an MOI of 1 for 48 hours (n=6). Supernatants were analyzed by
multiplex or ELISA assay for CCL2. (C-E) Iκκ2fl/fl Sftpc-cre mice and littermate controls were infected with HN878
for 14 (n=7) and 30 (n=5) d.p.i. and the accumulation of (C) AMs, (D) neutrophils, and (E) RMs were calculated by
flow cytometry. (F) Bacterial burden in the lung was determined by plating at 14 (n=7 per group) and 30 d.p.i. (n=5
per group) in Iκκ2fl/fl Sftpc-cre mice and littermate controls. (G) Confocal microscopy of lung sections stained for Ecadherin (red) and CCL2 (green) in Iκκ2fl/fl Sftpc-cre mice and littermate controls. AMs=Alveolar Macrophages,
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Neuts=Neutrophils, RMs=Recruited Macrophages. (A) 2-way ANOVA with Bonferroni post-test (B) 1-way ANOVA
with Tukey’s post-test. (C-F) Student’s t-test was used to compare between groups per time point.

2.2.3

CCR2 expression mediates AMs to egress from airways and localize within TB granulomas
CCL2 is produced by HN878-infected epithelial cells and DCs, and thus we next

examined if the CCR2 axis was involved in AM movement out of the airways. To address this,
we specifically labeled myeloid cells within the airways by delivering fluorophore-conjugated
CD45.2 antibody i.t. to Mtb HN878-infected mice prior to harvest (Supplementary Figure 4a-d,
Appendix). This technique allowed us to distinguish between BAL stain positive airway CCR2+
AMs (CD45.2+ CCR2+ CD11c+ SiglecF+) and BAL stain negative non-airway CCR2+ AMs that
are not exposed to the CD45.2 antibody (CD45.2− CCR2+ CD11c+ SiglecF+) (Figure 4A). To
validate the technique, we demonstrated that delivery of CD45.2 antibody into the airways does
not leak into the interstitium in naïve mice (Supplementary Figure 4d, Appendix). However,
when lung injury is induced in mice by i.t. instillation of hydrochloric acid (HCl), we observed
increased dispersion of CD45 antibody into the interstitium (Supplementary Figure 4d,
Appendix). Additionally, mice undergoing lung injury due to treatment with HCl showed
increased frequency of total lung cells and myeloid cells stained with CD45.2 antibody when
compared with CD45.2+ lung cells in naïve PBS-treated mice (Supplementary Figure 4a,
Appendix) Furthermore, when BAL was collected immediately after delivery of CD45.2
antibody i.t., we found that the airway localized AMs were ~99% CD45.2+ in both uninfected
and Mtb-infected mice (Supplementary Figure 4e, left panel, Appendix), though AMs were a
smaller proportion of the total airway cells during infection (Supplementary Figure 4e, right
panel, Appendix).
During Mtb infection, we observed an overall increase in AM accumulation in the lung
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(Figure 4B). In addition, we found that early during infection, of the airway labeled myeloid
cells, AMs were the most represented cell type, followed by DCs (Figure 4C). However, as
infection progressed, neutrophils along with monocytes were increasingly represented in the
airway, while AMs were less represented (Figure 4C). We observed increased CCR2+ AM
accumulation early following infection, especially within the airways (Figure 4D). As infection
progressed, we observed decreased CD45.2+ CCR2+ AMs localizing within the airways and
increased non-airway CD45.2− CCR2+ AMs, suggesting either an egress of bonafide AMs from
the airway, or the presence of recruited, monocyte-derived, AM-like cells within the tissue
(Figure 4D). The timing of these changes in localization coincided with the timing of increased
CCR2 ligand expression in the lung at 21 d.p.i. (Figure 3A).
To determine the identity and functional relevance of the AM populations, we sorted for
highly purified airway AMs (~99% purity, Supplementary Figure 5a, Appendix) (CD45.2+
CD11c+ SiglecF+) from uninfected and infected mice, and non-airway AMs from infected mice
(~95% purity, Supplementary Figure 5a, Appendix) (CD45.2− CD11c+ SiglecF+) and carried
out RNA sequencing. We confirmed that both populations were in fact bonafide AMs by
examining the common AM gene signature115,300 between groups (i.e. Siglecf, Pparg, Tgfbr2,
Csf2r, Mertk, Itgax, Lyz2, and Fcgr1). We also confirmed that the AM populations did not highly
express genes associated with monocyte-derived interstitial or recruited macrophages67 (Ly6c1,
Itgam, and CD163)(Supplementary Table 1, 2a-b, Appendix). These data support our
hypothesis that the both airway and non-airway AMs are not interstitial monocyte-derived
macrophages67 but in fact bonafide AM populations.
According to the RNA-Seq analysis, non-airway AMs expressed significantly higher
mRNA levels (according to DESeq2301) for genes belonging to classical macrophage activation
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including inducible nitric oxide synthase (Nos2), CD40 antigen (Cd40), S100 calcium binding
protein A8 (S100a8), Guanylate binding protein 2 (Gbp2), Lysozyme 1 (Lyz1) and Lipocalin
(Lcn2), when compared with sorted airway AMs (Figure 4E and Supplementary Table 3, see
Dunlap et al, 2018). Additionally, non-airway AMs also expressed significantly higher mRNA
for genes such as Matrix metallopeptidases (Mmp2, Mmp14) and proinflammatory chemokines
such as Cxcl9, Cxcl16. In addition, mRNA belonging to classical macrophage transcriptional
signatures such as Basic leucine zipper transcription factor, ATF-like 2 (Batf2)302 and Interferon
regulatory factor 8 (Irf8),303 were significantly higher in sorted non-airway AMs than airway
AMs. Transcriptional profiles of non-airway AMs when compared with airway AMs showed
significantly higher expression of pathways associated with infections, complement cascade, and
the phagosome activation (Supplementary Table 4, Appendix).
Alternatively, only 12 genes were significantly expressed at higher levels in airway AMs
during infection, when compared with non-airway AMs isolated from Mtb-infected mice (Figure
4E and Supplementary Table 5, Appendix), including inhibitor of DNA binding 1304 (Id1;
expressed by tissue-resident macrophages) and growth differentiation factor-15 (Gdf15), which
has been reported to drive expression of CCR2 in macrophages.305 Further, significantly higher
gene expression in airway AMs was observed for TLR-induced inflammatory responses such as
Polo-like kinase 3 (Plk3)306 and Pleckstrin homology like domain, family A, member 1
(Phlda1)307 and the cholesterol–trafficking START domain containing 9 (Stard9) genes. Genes
significantly higher in airway AMs from infected mice compared to uninfected mice
demonstrated significant enrichment for pathways associated with metabolic pathways, antigen
processing and phagocytosis (Supplementary Table 6, see Dunlap et al, 2018). In addition,
genes associated with several key signaling pathways associated with cytoskeletal rearrangement
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and diapedesis were downregulated during infection in airway AMs (Supplementary Table 7,
see Dunlap et al, 2018). Together, our results indicate that airways AMs during infection
upregulate a unique transcriptional signature associated with phagocytosis and antigenpresentation, when compared to non-airway AMs, who are more classically activated for
intracellular killing and T cell activation.
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Figure 4: CCR2 expression is required for AMs to egress from airways and localize within TB granulomas.
Single cell lung suspensions from uninfected and infected mice (n=5) were prepared and (A) the gating strategy for
airway and non-airway AMs is shown. The percentage and number of specific cell subsets with airway label CD45.2
delivered i.t. is shown. CD11c+CD11bloSiglecF+CD45.2+ cells were gated as airway AMs, while
CD11c+CD11blo SiglecF+ CD45.2− cells were gated as non-airway AMs. (B) The total number of AMs over the time
course of HN878 in B6 mice was determined by flow cytometry (n=5 per time point). (C) From total airway labelled
cells (CD45.2+), the percentage of each myeloid cell type was determined in HN878-infected B6 mice by flow
cytometry. (D) Total CCR2+ AMs, CCR2+ airway (CD45.2+) AMs, and CCR2+ non-airway (CD45.2−) AMs over the
course of HN878 infection in B6 mice were determined by flow cytometry. (E) Z-score Pearson correlation-based
clustering of differentially expressed genes of interest (all 12 significantly differentially expressed genes in airway
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AMs, and 29 genes of functional interest that were higher in non-airway AMs). AMs=Alveolar Macrophages,
Neuts=Neutrophils, Monos=Monocytes, RMs=Recruited Macrophages, mDCs=Myeloid Dendritic Cells,
MMPs=matrix metallopeptidases, PRRs=pattern recognition receptors. (B-D) Each time point was compared to
baseline d0 counts using Student’s t-test. (E) The gene expression levels of a subset of significantly differentially
expressed genes between airway and non-airway AMs (according to DESeq).

To mechanistically examine the ability of CCR2+ AMs to egress from the airways and
localize within the TB granulomas during HN878 infection, we used an adoptive transfer model
with CCR2-GFP-expressing AMs. We purified CD11c+ lung cells (Supplementary Figure 5b,
Appendix) from HN878-infected CCR2-GFP(+/KI) mice308 or CCR2-GFP(KI/KI) mice. CCR2GFP(+/KI) mice have one functional allele for CCR2, but also express GFP, while CCR2GFP(KI/KI) mice have both nonfunctional, GFP+ alleles. We adoptively transferred the CD11c+
cells into the airways of HN878-infected B6 mice, and using SiglecF to further identify AMs,
CD11c+ SiglecF+ CCR2-GFP+ AMs were tracked within TB granulomas (Figure 5A). We
observed that CD11c+ SiglecF+ CCR2-GFP(+/KI) AMs adoptively transferred into the airways
localized within the TB granulomas (Figure 5B). In contrast, adoptive transfer of CCR2GFP(KI/KI) AMs into the airways resulted in notably reduced accumulation within the TB
granulomas (Figure 5C). Furthermore, we observed increased migration of Mtb-stimulated
CCR2-GFP(+/KI) macrophages in response to HN878-infected but not H37Rv-infected epithelial
cell supernatant. However, Mtb-stimulated CCR2-GFP(KI/KI) macrophages did not migrate in
response to either Mtb-infected epithelial cell supernatants, suggesting that the macrophage
migration in response to infection is CCR2-dependent (Figure 5D). Furthermore, localization of
Ccl2 mRNA is within TB granulomas in HN878-infected B6 lungs, while Ccl2 mRNA
expression was localized outside of cavitary TB granulomas in CCR2−/− HN878-infected lungs
(Figure 5E). Additionally, a higher percentage of AMs were found in the airways of CCR2−/−
HN878-infected lungs when compared to B6 HN878-infected mice (Figure 5F). These data
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suggest that CCR2 plays a role in AM localization within the TB granuloma, and that without a
functional CCR2, AMs less efficiently migrate from the airways to localize within the TB
granulomas.

Figure 5: CCR2 is required for AM localization within TB granulomas. (A) CD11c+ cells were purified from
lungs of 30 d.p.i. HN878-infected CCR2-GFP(+/KI) or CCR2-GFP(KI/KI) mice and 106 cells were IT transferred into
B6 HN878-infected mice (n=5) at 30 d.p.i.(A-C) Lungs were harvested at 50 d.p.i. and examined for localization of
SiglecF+ GFP+ cells within TB granulomas using the morphometric tool of the Zeiss Axioplan microscope. (D) CCR2GFP(+/KI) or CCR2-GFP(KI/KI) BMDMs were stimulated in vitro with 20 μg/mL irradiated Mtb HN878 for 24
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hours. Migration towards uninfected, H37Rv- or HN878-infected epithelial cell supernatants was analyzed via
transwell chemotaxis assays and flow cytometry (n=3). (E) Ccl2 mRNA localization was determined within FFPE
lung sections from B6 and CCR2−/− HN878-infected using RNAScope in situ hybridization (ISH). Arrows point
to Ccl2 mRNA localization(brown). (F) B6 and CCR2−/− mice (n=5) were infected with HN878 and percentage of
AMs with airway label CD45.2 delivered IT was calculated on 14 d.p.i. by flow cytometry. Grav=Gravity control,
Un.=uninfected, AMs=Alveolar Macrophages. n=5 (B,C) Student’s t-test. n=3, (D) 2-Way ANOVA with Bonferroni
post-test. (F) Student’s t-test.

2.2.4 CCR2 expression at the time of airway AM egress is critical for control of Mtb HN878
infection
CCR2-DTR mice have DTR inserted between the first and second codon of CCR2,175 and
treatment of CCR2-DTR mice with diphtheria toxin (Dtx) resulted in depletion of all CCR2expressing cells. Previously, depletion of CCR2-expressing cells following Mtb Erdman
infection reduced monocyte and monocyte-derived populations, but did not result in increased
Mtb susceptibility.100 To address the timing of the CCR2 requirement for protection following
HN878 infection, we similarly used CCR2-DTR mice.100 CCR2-DTR mice were infected with
HN878, and CCR2-expressing cells were depleted either early at the time of infection (−1 to 5
d.p.i.) or later at the time of AM egress from the airways (12–18 d.p.i.) (Figure 4D). Transient
depletion of all CCR2-expressing cells around 12–18 d.p.i. but not at the time of infection
resulted in a significant increase in Mtb burden (Figure 6A-D). Depletion of CCR2-expressing
cells at 12–18 d.p.i. also resulted in increased accumulation of neutrophils, monocytes and RMs
in the lung and sharply decreased number of AMs, when compared to PBS treated Mtb-infected
mice (Figure 6B). Additionally, CCR2-DTR that received Dtx between 12–18 d.p.i. also showed
increased inflammation, when compared to control CCR2-DTR mice that received PBS (Figure
6C). In contrast, CCR2-DTR mice that received Dtx around the time of infection did not show
any differences in AM numbers, but showed decreased accumulation of neutrophils, monocytes
and RMs and coincident decreased inflammation (Figure 6E,F). Together, these results
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demonstrate that transient depletion of CCR2-expressing cells coincident with the time of AM
egress from the airways resulted in decreased AM accumulation and increased susceptibility to
HN878 infection. In contrast, depletion of CCR2-expressing cells around the time of infection,
while dampening RM and monocyte accumulation, did not impact AM accumulation and only
minimally increased Mtb control.
To further confirm the role of CCR2+ AMs in protection against HN878 Mtb infection,
we delivered B6 macrophages stimulated in vitro with irradiated Mtb into the airways of
CCR2−/− HN878-infected mice. Adoptive transfer of B6 macrophages rescued the increased
susceptibility observed in CCR2−/− HN878-infected mice, yielding decreased lung bacterial
burden equivalent to B6 HN878-infected mice (Figure 6G). These data suggest that the
susceptibility associated with CCR2−/− mice coincides with lack of macrophage accumulation in
the lung, and that adoptive transfer of B6 macrophages into airways is sufficient to reverse
susceptibility Mtb in CCR2−/− HN878-infected mice.
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Figure 6: Depletion of CCR2+ cells at the time of AM egress from airways increases susceptibility to HN878
infection. CCR2-DTR mice (n=4) were infected with HN878 and administered Dtx (A-C) IP at 12, 14, and 16 d.p.i.
or (D-F) at −1, 1, and 3 d.p.i. (A,D) Lung bacterial burden was determined by plating on 30 d.p.i. (B,E) Neutrophil,
AM, monocyte and RM numbers were determined in PBS-treated and Dtx-treated CCR2-DTR mice at 30 d.p.i. (C,F)
Pulmonary histology was assessed on FFPE lung sections stained with H&E, and inflammatory area was quantified
using the morphometric tool of the Zeiss Axioplan microscope. (G) B6 (n=5) and CCR2−/− mice (n=8 per group) were
infected with HN878, and CCR2−/− mice received either PBS or HN878-stimulated BMDMs delivered IT on 15 and
21 d.p.i. Lungs were harvested at 30 d.p.i. and bacterial burden was determined by plating. Neuts=Neutrophils,
AMs=Alveolar Macrophages, Monos=Monocytes, RMs=Recruited Macrophages. (A-F) Student’s t-test. (G) 1-way
ANOVA with Tukey’s post-test.
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2.2.5 Dependence on CCR2 for protective immunity to Mtb HN878 is not driven solely by PGL
expression
Recently, M. marinum expressing PGL has been shown to be involved in induction of
CCL2 and recruitment of CCR2-expressing permissive macrophages in zebrafish mycobacterial
infection model.144,145 Thus, we next addressed if absence of PGL in Mtb HN878 would result in
lack of a role for CCR2 in controlling Mtb HN878 infection in mice. Thus, B6 and CCR2−/− mice
were infected with a recombinant Mtb HN878 mutant harboring a mutation within pks1-15
(HN878 pks1-15::hygB) rendering Mtb PGL deficient.225 Upon infection with Mtb HN878 pks1–
15::hygB, CCR2−/− mice were still more susceptible to infection when compared with B6
infected mice (Figure 7A). This coincided with decreased accumulation of AMs, RMs and
monocytes, increased neutrophil accumulation, (Figure 7B) and severe pulmonary disease
(Figure 7C) in CCR2−/− infected mice when compared with B6 infected mice. Additionally,
while in vitro infection of macrophages and DCs with HN878 pks1–15::hygB resulted in
decreased CCL2 when compared to HN878 infection225 (Figure 7D), comparable induction of
CCL2 was observed upon infection of lung epithelial cells with HN878 and HN878 pks1–
15::hygB (Figure 7E). These data are also supported by localized expression of Ccl2 mRNA
within TB granulomas in lungs of B6 and CCR2−/− mice infected with HN878 pks1–15:hygB
(Figure 7F). These data suggest that PGL expression is not the only key determinant for a
protective role for CCR2 in Mtb HN878 infection, as Mtb H37Rv and HN878 also differ in
expression of several other key components in their cell walls.222
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Figure 7: Dependence on CCR2 for protective immunity to Mtb HN878 is not driven by PGL expression. B6
and CCR2−/− mice (n=5) were aerosol-infected with ~100 CFU HN878 pks1–15::hygB. (A) Lung bacterial burden
was determined by plating on 30 d.p.i. (B) Lung myeloid cell populations of AMs, RMs, monocytes and neutrophils
were enumerated in B6 and CCR2−/− HN878 pks1–15:hygB infected mice using flow cytometry. (C) Pulmonary
histology was assessed on FFPE lung sections stained with H&E, and inflammatory area was quantified using the
morphometric tool of the Zeiss Axioplan microscope. (D-F) BMDCs, BMDMs, and C10 epithelial cells were cultured
and infected with indicated Mtb strains at an MOI of 1 for 48 hours (n=5). Supernatants 34 were analyzed by multiplex
or ELISA assay for CCL2. (G) Ccl2 mRNA localization was determined within FFPE lung sections from B6 and
CCR2−/− HN878-infected using RNA Scope in situ hybridization (ISH). Arrows point to Ccl2 mRNA localization
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(brown). AMs=Alveolar Macrophages, RMs=Recruited Macrophages, Monos=Monocytes, Neuts=Neutrophils. (AC) Student’s t-test. (D-F) 1-way ANOVA with Tukey’s post-test.

2.3

Materials and Methods

Mice
C57BL/6J (B6), CCR2−/−, 174 and CCL2−/− 309 mice on the B6 background were purchased
from The Jackson Laboratory (Bar Harbor, ME). CCR2-DTR175 and CCR2-GFP 308 were a kind
gift from Drs. Robyn Klein and Marco Colonna at Washington University School of Medicine
and bred in-house. Iκκ2fl/fl Sftpc-cre298 were a kind gift from Dr. Pasparakis (University of
Cologne). CCR2-DTR mice were administered sterile PBS or 20 ng Dtx/g body weight (VWR,
Radnor, PA) approximately 500 ng/mouse in 200 μL sterile PBS, intraperitoneally (i.p.), 3 times
as indicated.
All mice were maintained in the animal facility at Washington University in St. Louis
and bred in-house. Experimental mice were age and sex matched and infected between the ages
of 6 and 8 weeks. All mice were maintained and used in accordance with the approved
Washington University in St. Louis Institutional Animal Care and Use Committee guidelines.
Both male and female mice were used and to our knowledge no sex-based differences were
observed.
Mtb Strains and Experimental Infections
Mtb strains H37Rv (Trudeau Institute), CDC1551, HN878, and HN563 were obtained
from BEI Resources (Manassas, VA) under National Institutes of Health contract AI-75320.
HN878 pks1-15::hygB was used as previously published.225 H37Rv-GFP and HN878-GFP was
transformed with the integrating EGFP expression vector pMV261.kan (provided by Dr.
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Christina Stallings, Washington University in St. Louis) to generate GFP-expressing Mtb. IndoOceanic T17x strain was acquired from Dr. Karen M. Dobos, Colorado State University. All Mtb
strains were cultured in Proskauer Beck medium supplemented with 0.05% Tween 80 and frozen
at −80 °C while in mid-log phase. Mice were aerosol-infected with low doses (~100 CFU) of
indicated Mtb strains in sterile PBS using a Glas-col nebulizer.310 Mice were monitored and
weighed as needed and lungs and spleens were harvested at described time points. Mtb
CFU/organ was quantitated by plating serial dilutions of homogenized lung or spleen tissue on
7H11 agar plates (BD Biosciences, Franklin Lakes, NJ). Plates were incubated for 2–3 weeks at
37 °C and colonies were counted visually.
In Vitro Culture
Mouse epithelial C10 cells were cultured in complete Dulbecco’s modified eagle’s
medium (cDMEM) to confluence for approximately 2 days. Counts from a representative well
were used to calculate the concentration of C10 cells/well, performed visually by
hemocytometer.
Bone marrow-derived macrophages (BMDMs) and bone marrow-derived DCs (BMDCs)
were cultured from bone marrow cells as previously described.311 Briefly, bone marrow cells
from the femur and tibia of B6 and gene deficient mice were extracted, and 1 × 107 cells were
plated in 10 mL of cDMEM supplemented with 20 ng/mL mouse recombinant (rm) granulocytemacrophage colony-stimulating factor (GM-CSF) (Peprotech, Rocky Hill, NJ).310 Cells were
then cultured at 37 °C in 5% CO2. On day 3, 10 mL of cDMEM containing 20 ng/mL rmGMCSF was added. On day 7, adherent cells were collected as macrophages and non-adherent cells
were collected as DCs.
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Chemotaxis Assay
BMDMs were grown as above, and plated at 2 × 106/mL and stimulated with 20 μg/mL
irradiated Mtb HN878 (BEI) for 24 h in cDMEM at 37 °C. BMDMs were then added to the upper
chamber of the 24-well transwell plate (Costar, Cambridge, CA), 1 × 105 cells/well in 100 μL of
Hank’s balanced salt solution containing 1% fetal bovine serum with 600 μL of indicated
conditioned media beneath the transwell in a 24-well plate. These were incubated for 90 min at
37 °C, then transmigrated cells were collected from the lower chamber, stained and analyzed by
flow cytometry.
In Vitro Infections
BMDMs, BMDCs, and C10 epithelial cells were infected with Mtb (multiplicity of
infection, MOI:1) in antibiotic-free cDMEM. Cell culture supernatants were collected for
analysis of cytokines 48 hours post infection.
Adoptive transfer
Lung cell suspensions were prepared as before from the lungs of donor CCR2-GFP (+/KI
or KI/KI) mice on 30 d.p.i. following Mtb HN878 infection. CD11c+ cells were enriched from
the lung suspension using magnetic selection with CD11c microbeads (Miltenyi Biotec, Auburn,
CA) per manufacturer’s instructions, yielding a population of (>85%) CD11c+ cells. These cells
were resuspended at 1 × 107 cells in 500 μL sterile PBS. 50 μL (1 × 106 cells) of this suspension
was administered i.t. to HN878-infected mice at 30 d.p.i. These mice were harvested on 50 d.p.i.
as indicated.
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BMDMs were grown as above, and plated at 2 × 106 cells/mL and stimulated with 20 μg/mL
irradiated Mtb HN878 (BEI) for 24 hours in cDMEM at 37 °C. These cells were then harvested
and resuspended at 1 × 107 cells in 500 μL sterile PBS. 50 μL (1 × 106 cells) of this suspension
was administered i.t. to HN878-infected mice at 15 and 22 or 30 d.p.i. as indicated.
Flow Cytometry
For distinguishing between airway and non-airway cells, mice received 0.7 μg of V500 or
PE-conjugated CD45.2 mAb (Clone 104, BD Biosciences and Biolegend, San Diego, CA),
administered i.t. in 50 μL sterile PBS per mouse. Mice were rested for 15 min following which
lungs were harvested. To validate the technique some mice received 50 uL of HCl in sterile
water (pH 1.5) i.t. and rested for 24 hours prior to instillation of CD45.2 antibody. 313
Lung single cell suspensions were prepared as before,310 treated with Fc Block
(CD16/CD32, 2.4G2, Tonbo Biosciences, San Diego, CA), and stained with appropriate
fluorochrome-labeled specific antibodies or isotype control antibodies: CD11c (HL3, BD
Biosciences), CD11b (M1/70, BD Biosciences and Tonbo Biosciences), SiglecF (E50-2440, BD
Biosciences), CD64(X54-5/7.1, Biolegend), Gr-1 (RB6-8C5, BD Biosciences), CCR2
(FAB5538P, R&D Systems), CX3CR1 (SA011F11, Biolegend), Ly6C (AL21, BD Biosciences),
Ly6G (1A8, BD Biosciences), CD3 (145-2C11, Tonbo Biosciences), CD4 (GK1.5, BD
Biosciences), CD44 (IM7, eBioscience), IFN-γ (XMG1.2, BD Biosciences), and rat IgG1 (BD
Biosciences).
Cells were processed using a Becton Dickinson FACS LSR Fortessa flow cytometer
using FACSDiva software, or sorted on a Becton Dickinson FACSJazz cell sorter using BD
FACS sorting software. Cells were gated based on their forward and side scatter characteristics
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and the frequency of specific cell types was calculated using FlowJo (FlowJo, LLC, Ashland,
OR). Neutrophils were defined as CD11b+CD11c−Gr-1hi cells, monocytes were defined as
CD11b+CD11c−Gr-1lo cells, and RMs were defined as CD11b+CD11c−Gr-1− cells. mDCs were
defined as CD11b+CD11c+ cells. AMs were defined as CD11bloCD11c+ cells (Fig. 1) and
subsequently as CD11bloCD11c+SiglecF+ cells. The flow cytometry gating strategy used for lung
subset analysis was an approach using our i.t. labeling method to select for airway populations
and a combined gating strategy from several previous publications.114,312-315

314–318

For uptake experiments, lung cell suspensions were prepared from H37Rv-GFP- or
HN878-GFP-infected B6 mice and stained with appropriate fluorochrome-labeled specific
antibodies. Uptake was determined by the co-localization of GFP with known fluorophoreconjugated cell subset markers as measured by flow cytometry.
Bronchoalveolar Lavage (BAL)
Mice were administered i.t. CD45.2 Ab as above and ~10 min later euthanized. BAL was
then performed as previously described.172,191 Briefly, the chest cavity was opened and the
sternum/ribcage was resected. The trachea was isolated and a blunt tipped needle was gently
inserted into the trachea. The lungs were lavaged with ~5 (5 × 1 mL) washes with sterile 0.2 mM
EDTA (Sigma-Aldrich) in PBS. Cells were collected from these lavages and analyzed by flow
cytometry as above.
RNA Extraction and Quantitative Real-Time PCR (qRT-PCR)
Lung tissue was homogenized and snap-frozen in RLT buffer (Qiagen, Valencia, CA).
Total RNA was extracted from lung tissue using the Qiagen RNeasy Mini kit (Qiagen). RNA
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was converted to cDNA using ABI reverse transcription reagents (ABI/ThermoFisher Scientific,
Carlsbad, CA) using a BioRad DNA Engine Thermal Cycler (BioRad, Hercules, CA). cDNA
was then amplified using TaqMan reagents on the ABI Viia7 Real-Time PCR detection system
(ThermoFisher Scientific). The primer and probe sequences for murine glyceraldehyde 3phosphate dehydrogenase (Gapdh) and Tnfα were previously published.316 The primers and
probes for murine Arg1, Ccl2, Ccl7, and Ccl12 were purchased commercially (ABI Biosystems).
The primer and probe sequences for Tgfb1 are forward 5′-TGACGTCACTGGAGTTGTACGG3′, reverse 5′-GGTTCATGTCATGGATGGTGC-3′, probe 5′-/56-FAM/TTC AGC GCT CAC
TGC TCT TGT GAC AG/3BHQ_1/-3′. Fold increase was determined over uninfected controls
relative to Gapdh expression using the ΔΔCT calculation as previously described. 316
RNA-Sequencing of AM Populations
AMs were sorted and RNA was extracted as described above. RNA sequencing libraries
were generated using Clontech SMART-Seq v4 Ultra Low Input RNA Kit for sequencing and
Illumina Nextera XT DNA Library preparation kit following the manufacturer’s protocol. The
cDNA libraries were validated using KAPA Biosystems primer premix kit with Illuminacompatible DNA primers and quality was examined using Agilent Tapestation 2200. The cDNA
libraries were pooled at a final concentration of 1.8 pM. Cluster generation and 75 bp paired-read
dual-indexed sequencing were performed on Illumina NextSeq 500. Single-ended 75 bp reads
were cleaned using Trimmomatic (version 0.36) to remove adapters and quality trimmed to filter
out reads <60 bp in length (after trimming). Cleaned sequence data was mapped against the
mouse reference genome build GRCh38.90 (Ensembl) using the HISAT2317 aligner (version
2.1.0) with default parameters, generating sam format alignment files. These sam files were then
used as input for featureCounts (version 1.5.1), requiring a minimum mapping quality score of
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10. Raw read counts were used as input for DESeq2301 (version 1.16.1) differential expression
analysis, using default settings and an FDR-adjusted P value threshold of 0.05 for significant
differential expression. Lists of differentially expressed genes were used to test for significant
enrichment among KEGG pathways318 and Mammalian Phenotype Ontology,319 using
WebGestalt320 (default settings, adjusted P = 0.05 threshold for enrichment). Heatmap clustering
was performed using “hclust” in R, using Pearson distances and complete linkage, based on Zscores calculated per row using Microsoft Excel.
Histology
Lung lobes were perfused with 10% neutral buffered formalin and embedded in paraffin.
For immunofluorescent staining, formalin-fixed paraffin-embedded (FFPE) lung sections were
cut, immersed in xylene to remove paraffin, and then sequentially hydrated in absolute ethanol,
95% ethanol, 70% ethanol, and water. Antigens were unmasked with a DakoCytomation Target
Retrieval Solution (Dako, Carpinteria, CA) and nonspecific binding was blocked with 5% (v/v)
normal donkey serum and Fc Block (BD Pharmingen, San Jose, CA). Endogenous biotin
(Sigma-Aldrich) was neutralized by adding avidin followed by incubation with biotin.

Antibodies for Histological Identification of Lung Cells:
Rabbit anti-Mtb antibody, (MBS534825, MyBiosource.com)
Rabbit anti MCP-1/CCL2 (GTX37379, GeneTex, Irvine, CA)
Goat anti-human/mouse E-Cadherin (AF748, R&D Systems)
Monoclonal hamster anti-ITGAX/CD11c (N418, Lifespan Biosciences, Inc., Seattle, WA)
Polyclonal rabbit anti-Siglec 5/CD170 (LS-C97825, Lifespan Biosciences, Inc.).
Fluorescein (FITC) affinipure F(ab’)2 fragment donkey anti-rabbit IgG (H+L) (711-096-152,
Jackson Immunoresearch, West Grove, PA).
Biotin-SP (long spacer) affinipure F(ab’)2 fragment rabbit anti-Syrian hamster IgG (H+L) (307066-003, Jackson Immunoresearch).
Streptavidin, Alexa Fluor® 488 conjugate (S-11223, ThermoFisher Scientific).
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Biotinylated goat anti-GFP (GTX26658, Genetex, Irvine, CA) was visualized with Alexa
Fluor 568 donkey anti-goat IgG and Alexa Fluor 555 streptavidin. GFP stain was pseudocolored
to green with the Axiovision software. Images were collected using an inverted Observer.Z1
Axioplan Zeiss Microscope with Colibri system (Zeiss, Thornwood, NY) and the Axiovision Rel
4.8. Software.
FFPE lung sections were stained with hematoxylin and eosin (H&E) and inflammatory
features were evaluated by light microscopy. Inflammatory lesions were outlined with the
automated tool of the Zeiss Axioplan 2 microscope (Carl Zeiss) and percentage of inflammation
was calculated by dividing the inflammatory area by the total area of individual lung lobes. FFPE
lung sections were stained for collagen and muscle using Masson’s Trichrome 2000 stain
procedure kit (#KTMTR2, American Mastertech, Lodi, CA) per the manufacturer’s instructions.
Trichrome stained slide images were acquired using a Hamamatsu Nanozoomer 2.0 HT system
with NDP scan image acquisition software. Trichrome staining was quantified using Visiomorph
image processing software (Visiopharm, Broomfield, CO). FFPE lung sections were subjected to
in situ hybridization (ISH) with the mouse-Ccl2 probe using the RNAscope 2.5HD Detection Kit
(Brown staining) as per the manufacturer’s recommendations (Advanced Cell Diagnostics,
Newark, CA). The representative pictures were taken with the Hamamatsu Nanozoomer 2.0 HT
system with NDP scan image acquisition software.
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Cytokine Production Quantification
Cytokine levels within cell culture supernatants were analyzed using the BD OptEIA
Mouse CCL2 ELISA kit (BD Biosciences) or using Milliplex Multiplex Assays (Millipore,
Billerica, MA), as per standard protocol.
Statistical Analyses
Statistical analyses were performed using GraphPad Prism 5 and Microsoft Excel.
Specific analysis techniques and post tests are mentioned in figure legends. SEM error bars
displayed. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, n.s.—not significant.

2.4

Discussion and Conclusions
In humans, polymorphisms in Ccl2 have been associated with pulmonary TB,288 while

mouse infection studies have shown that CCR2 expression is dispensable for protective
immunity to infection with aerosolized Euro-American lineage 4 Mtb strains.176 Zebrafish
modeling of granulomas using M. marinum has proposed that the CCR2–CCL2 axis through
interactions with virulence factors drives the generation of permissive macrophages and
promotes mycobacterial replication and pathogenesis.144,145,176 In the current study, using murine
models, we provide novel evidence that the CCR2 axis is critical for protective immunity against
infection with emerging Mtb lineages, such as the W-Beijing family of Mtb strains. Our data
demonstrate that AMs express CCR2 that is required for localization of AMs within the TB
granulomas. In the absence of CCR2, AMs fail to localize within TB granulomas, resulting
instead in accumulation of neutrophils and development of necrotic TB lesions, a characteristic
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of failed immunity in TB. Additionally, we show that the requirement for CCR2 for protective
immunity to Mtb HN878 is not solely dependent on expression of PGL and PGL-mediated
modulation of this chemokine axis. Thus, our study provides novel insights by projecting that
CCR2 expression, especially on AMs, is required for protective immunity against emerging Mtb
strains.
AMs are a tissue-resident macrophage lineage that under homeostatic conditions are
believed to mature during neonatal development.312 However, under conditions of inflammation,
inflammatory monocytes, perhaps through a transient lung-resident macrophage population may
also give rise to AMs.312 During Mtb infection, although it is widely believed that tissue-resident
AMs are the primary innate cell type that are infected, the functional relevance of AMs during
Mtb infection is unclear.321 Utilizing the zebrafish granuloma model, it has been shown that M.
marinum can be transported across neuroepithelial barriers by macrophages and results in CCL2mediated recruitment of permissive monocyte-derived macrophages that mediate formation of
the granuloma to enhance disease pathogenesis.144,145 Using a murine model, our studies here
show that following infection with Mtb HN878, bonafide AMs increase in the lung following
Mtb infection, and they localize within the airway. As infection progresses and TB granulomas
form, our results show that AMs respond to CCL2-dependent chemokine signals likely from lung
epithelial cells to egress from the airways. Furthermore, adoptive transfer of CD11c+ SiglecF+
AMs expressing CCR2 localized within granulomas, and AMs not expressing CCR2 did not
localize within granulomas, suggesting that AMs may require CCR2 expression to respond to
epithelial signals and localize into granulomas. Additionally, we show that HN878 pks115::hygB infection still results in increased susceptibility in CCR2−/− mice. Thus, the protective
versus disease-promoting features of the CCR2 axis and AMs in mycobacterial infections in
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mouse versus zebrafish model may be due to (1) differences in the animal models used, (2) a
specific feature of AM trafficking from airways that are not observed in zebrafish macrophages,
or (3) due to the fact that M. marinum PGLs contain a monosaccharide while Mtb PGL contain a
trisaccharide domain.261
Ligands for CCR2, namely CCL2, CCL7, and CCL12 are induced in response to Mtb
infection in mice, non-human primates, and humans.322-324 Despite this, studies in the last decade
have shown that CCR2−/− mice display negligible or low susceptibility to low dose aerosolized
Mtb infection belonging to the Euro-American lineage 4, such as H37Rv and Erdman.176,291 Our
data show that when W-Beijing family lineage 2 clinical Mtb strains are used, the absence of
CCR2 in the CCR2−/− or deletion of CCR2 in CCR2-DTR mice render mice more susceptible to
infection, with coincident defects in macrophage accumulation, instead promoting neutrophil
accumulation, an immune cell type associated with failed immunity.189,294-296 The influx of
neutrophils may be a direct response to the tissue damage and inflammatory environment
brought on by the lack of apoptotic clearance and anti-inflammatory signaling of AMs.106 This
increase in susceptibility in CCR2−/− mice is not just limited to lineage 2 but also to clinical
isolates within the Euro-American lineage and Indo-Oceanic lineages, albeit not to the same
extent as in W-Beijing family Mtb infection. The observation that infection with the Mtb HN878
mutant lacking PGLs still requires CCR2 for AM accumulation and protective immunity
supports the idea that expression of other factors by emerging Mtb strains are likely involved. It
is possible that the observed Mtb strain-dependent response is due to distinct cellular responses
brought on by pattern recognition and phagocytic receptor interactions with Mtb strain-specific
membrane lipids and virulence factors.222 This is supported by published data that Mtbassociated membrane lipids and other virulence factors lead to differential transcriptional and
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metabolic profiles in macrophages.186,325,326
Upon infection with Streptococcus, AMs can leave the airway to migrate to lymph nodes
to transport bacteria.141 However, whether AMs can egress from the airway and participate in
immune responses locally within the lung was unknown up to this point. In our study, we find
that airway AMs apart from expressing the core macrophage signature genes, also express a
unique transcriptional signature. Furthermore, airway AMs upon Mtb infection upregulate
transcriptional pathways associated with antigen presentation and phagosome maturation. Using
a novel IT labeling technique, we show that CCR2+ AMs are present within airways during early
stages of Mtb infection. As the disease progresses, airway AMs can likely respond to chemokine
signals from lung epithelial cells (and other cells such as DCs) and egress from the airway and
localize within TB granulomas. Upon localization within granulomas, non-airway AMs can
undergo classical activation including the production of iNOS, upregulation of genes associated
with inflammation, pattern recognition receptors, and T-cell costimulation thereby providing
optimal Mtb control. Whether the activation of non-airway AMs is due to localization within the
inflammatory granulomas and dependent on signals within the granuloma is yet to be studied.
This airway labeling technique we have developed can be useful in the study of airwaylocalized immune cell types in the lung, including the localization of AMs, monocytes, DCs, and
neutrophils in the airways versus lung tissue. While this labeling technique can be useful for
tracking early cellular changes in the airways as in this study, upon formation of granulomas and
disease progression to chronic stages of infection, the structural integrity of the lung airway
epithelium can be compromised and may be a caveat as airway administered antibody may leak,
thus also labeling non-airway cells. Furthermore, with time, fluid accumulation and scarring may
occur in the airway, leading to less effective labeling of airway cells. These caveats should be
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carefully considered in the use of this labeling technique during chronic stages of infection, or
under conditions of loss of structural integrity or tissue scarring.
In summary, we show that CCR2 expression, while dispensable for protection against
Mtb lineage 4 infections, is critical for protection against emerging Mtb strains. Together our
data show that during early HN878 infection, AMs upregulate CCR2 and accumulate in the
airways. As the infection progresses, some AMs remain in the airway where they likely continue
to phagocytose and process TB antigen. Other CCR2+ AMs egress in response to the production
of CCL2 by epithelial cells or DCs around forming granulomas and interact with other
inflammatory cells to become classically activated and potentially localize within organized
granulomas to mediate Mtb control. Thus, our results provide novel insights into the role of AMs
and the CCR2 axis in macrophage anti-microbial mechanisms of protection against Mtb
infection.
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Chapter 3: The role of Iκκ
κκ2/NF-κ
κB signaling
κκ
in modulating AM effector functions and
global pulmonary immune responses to Mtb
infection
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3.1

Introduction

Mtb, the causative agent of pulmonary TB, is one of the leading causes of death
worldwide, infecting approximately one fourth of the world’s human population and killing
approximately 1.3 million people per year.1 While this death toll is staggering, approximately 9095% of infected people have LTBI, and remain mostly asymptomatic with no clinical hallmarks
of disease or overt inflammation. However, approximately 5-10% of the estimated 2 billion
humans infected with Mtb will develop ATB during their lifetime, presenting an urgent global
health crisis.1 Despite these shocking figures, we do not have an effective vaccine to treat adult
pulmonary disease.
One of the greatest barriers to developing better vaccine treatments for TB is our poor
understanding of the early host response mechanisms that mediate protective immunity against
Mtb infection. Most current vaccine strategies aim to induce protective adaptive immune
responses targeting helper CD4+ T-cells13,16-20 or B cells/antibodies.170,244,286,287,327 Unfortunately,
adaptive immune responses to Mtb are weeks slower than similar responses to other pulmonary
infections. This is due to delayed interactions between pulmonary DCs and CD4+ T-cells in the
lung dLNs,21,22,103,142,280 which slows peak adaptive immune responses until roughly one month
after Mtb exposure.23 Because of this delay, current research characterizing protective human
immune responses to Mtb infection focus on predictive host biomarkers antecedent to ATB
conversion and onset of adaptive immunity. In humans and multiple model organisms, blood
biomarkers such as Type 1 IFNs11 and S100A8/912,14 can be used to accurately predict
conversion to ATB in LTBI individuals. These studies correlate early inflammatory mediators
and protective immunity, thus suggesting a role for innate responses in early TB defense.26-28,328
Interestingly, an incident almost a century ago29,30 demonstrated that in some cases
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adaptive immunity may not be required for protection. In the winter of 1929-1930 at the Lübeck
General Hospital in Germany, 251 infants were accidentally given a BCG vaccine course
contaminated with live Mtb.29,30 Approximately ⅓ of these infants succumbed to TB
complications. Surprisingly, approximately ⅓ recovered after moderate to severe TB disease and
the remaining ⅓ displayed only mild symptoms.25,30 This tragedy demonstrated that innate
immunity alone could variably clear high dose Mtb infection in the surviving 2/3 of the cohort,
as human infants do not yet have robustly developed adaptive immune repertoires at this age.
Beyond the Lübeck disaster, there is a growing body of evidence suggesting that early
responses driven by innate immune cells can entirely prevent the establishment of infection, a
concept called early clearance.25 Indeed, a meta-analysis of 41 human studies found that
approximately 50% of highly exposed household contacts of TB patients remain uninfected long
term with no evidence of adaptive immunity.24,25 Similarly, innate immune determinates have
been associated with resistance to infection.26-28,328 Early pulmonary responses are driven by
local innate immune cells, mainly airway AMs, DCs, and AECs. Interestingly, Mtb DNA, but not
live bacteria, have been observed in AMs and AECs of otherwise histologically normal tissue,26
suggesting the ability of these cells to clear Mtb. Together, these lines of evidence demonstrate a
critical role for early innate responses in preventing Mtb establishment and early pathogenesis.
These findings provide an attractive therapeutic alternative compared to current approaches of
treating and controlling disease after onset of ATB disease.
Despite being the key initiators of the pulmonary immune response, characterizing the
role of innate phagocytes like AMs during infection has proven difficult. Depletion of AMs in
various pulmonary infection models have yielded mixed results.94-99 Depletion of airway AMs
and mDCs by clodronate liposomes improved disease outcomes, marked by increased T-cell
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priming100 and decreased total Mtb burden, pulmonary inflammation and damage.96 In other
studies, transient depletion of AMs and mDCs utilizing transgenic DTR models exacerbated
inflammation and drove severe pulmonary infection with Mtb, Francisella tularensis, Influenza
or RSV.98,99,103-105 These mixed findings demonstrate that AMs may play divergent roles in
pulmonary infection. To our current knowledge, no studies have observed AMs/mDC depletion
to have no effect on pulmonary immune responses, thus demonstrating these cells are critical for
the benefit of either the pathogen or the host.
Comparing the divergent roles of AMs during pulmonary infection requires examining
M1 and M2 polarization, which is a useful convention for determining functional responses to a
variety of infectious or inflammatory contexts.67,109 M2 profiles are driven by mammalian target
of rapamycin (mTOR) and peroxisome proliferator-activated receptor gamma (PPAR-γ), the
major signaling nodes induced by type 2 cytokines IL-4 and IL-13.329,330 These pathways are
critical for M2 polarization and AM steady state development.330-333 M2 responses are
characterized by expression of Arg1 and production of IL-10 and TGF-β,91,334-337 which drive
tissue remodeling and repair responses after large scale damage.76,78,106-108 In pulmonary Mtb
infection, M2 polarization drives decreased iNOS production and inhibited microbicidal
function, decreased pro-inflammatory cytokine production,110-112 and a metabolic shift to fatty
acid oxidation (FAO). FAO improves nutrient availability and provides a hospitable environment
for Mtb,67 therefore suggesting AMs are permissive to Mtb replication and persistence.67,109,121,122
M1 polarization is induced by recognition of microbial PAMPs and inflammatory type 1
cytokines such as IFN-γ and TNF-α.330 M1 polarization improves phagocytosis, iNOS
production and microbicidal function to drive a hostile environment for Mtb. M1 profiles are also
marked by a metabolic shift to glycolysis67,89,109 that correlates with pro-inflammatory cytokine
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production. 110-112 338,339 Previous work demonstrated that non-airway AMs upregulated multiple
functional pathways associated with M1 polarization and NF-κB,113,126 which is the major nexus
of pro-inflammatory signaling driven by pathogen sensing pathways. Interestingly, M1
polarization is negatively regulated by Iκκ2, a member of the NF-κB complex involved in
enhancing activation. Using pharmacological approaches138 and/or genetic models,139,140
inhibiting Iκκ2 drove increased MHC-II expression and inflammatory cytokine production on
macrophages, suggesting improved M1 polarization. Furthermore, NF-κB inhibition surprisingly
yielded increased Mtb control in vitro in primary human macrophages,138 also supporting this
hypothesis. These studies therefore provided us with a concise target for examining M1/M2 roles
of airway and non-airway AMs by focusing on Iκκ2/ NF-κB.
In the current study, we aimed to determine how the factors Iκκ2 and NF-κB specifically
modulate M1 activation of migrating AMs during Mtb infection. We examined how these
inflammatory nodes modulate effector functions of AMs and long-term disease outcomes.
Establishing a link between specific inflammatory signaling components, macrophage effector
functions, and disease outcomes will allow us to elucidate potential druggable targets for
inducing protective host responses during pulmonary infection. Taken together with prior
evidence for early clearance, we hypothesized that AMs may become M1 polarized to drive
protective pro-inflammatory responses in vivo that can clear Mtb infection.26
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3.2

Results

3.2.1

Abrogated Iκκ2 modulates cytokine production in CD11c expressing phagocytes

In previous studies, it was demonstrated that non-airway localized AMs upregulated M1
activation effector functions.113,126 Several of these specific pathways and genes are directly
downstream of NF-κB,137,340 thus suggesting this key signaling node was likely involved in the
bifurcation of AM effector responses during Mtb infection. To test this, we utilized the ikk2-fl/fl
(Iκκ2fl/fl) mouse113,298 crossed to a itgax-cre (CD11c-cre) for CD11c+ expressing cells,341,342
which specifically targets AMs and mDCs.
We validated decreased levels of Iκκ2 protein in vitro by measuring uninfected and Mtb
infected cell culture lysates. We utilized either sorted lung CD11c+ cells, or BMDMs and
BMDCs, which also highly express CD11c.343-345 We observed approximately ~90% decreased
Iκκ2 levels in infected CD11c+ lung cells (Figure 8A), and approximately ~50% and ~66%
decreased Iκκ2 levels in infected BMDMs (left panel) and BMDCs (right panel), respectively
(Figure 8B).
To examine a functional output of Iκκ2 reduction on NF-κB activity, we then quantified
inflammatory cytokine output from the above culture supernatants. We observed opposite trends
in the two models, with increased production of IL-6 and IL-1β in the CD11c+ sorted lung cells
(Figure 8C) and decreased production of IL-6 and IL-1β in both bone marrow cell types (Figure
8D). These differences are likely influenced by the culture conditions and compartment of origin,
which drastically alters cytokine production and function in macrophages.343-345 Interestingly, we
also observed increased cytokine production in the CD11c- fraction from the lung. Though these
CD11c- cells are unaffected by the cre-flox system, it is likely that cellular interactions are
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skewed by the altered cytokine production within AMs/mDCs, which may lead to a generally
hyper-inflammatory environment at steady state. It was previously demonstrated that Iκκ2
negatively regulates M1 activation,139,140 thus suggesting that our model may yield M1 “prepolarized” AMs in the lung and heightened inflammation even at steady state that could have farreaching effects on other cellular compartments.
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Figure 8: Abrogated Iκκ
κκ2
κκ modulates cytokine production in CD11c expressing phagocytes. A) Magnetically
sorted CD11c+ cells from whole lung cell suspensions from littermate or CD11c-cre Iκκ2fl/fl mice were infected with
Mtb H37Rv at MOI=0.1 for 3 days. B) BMDMs and BMDCs from littermate or CD11c-cre Iκκ2fl/fl mice were cultured
and infected with Mtb H37Rv at an MOI of 1 for 3 days (n=3) A&B) Western blots for Iκκ2 and GAPDH were
performed on lysates from collected cells at 3 d.p.i.. Relative density of Iκκ2 over Gapdh was quantified using ImageJ
analysis. C&D) Supernatants from infected cells were analyzed by ELISA assay for the indicated cytokines IL-6 and
IL-1β
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3.2.2 Decreased Iκκ2 in CD11c+ phagocytes drives early increased inflammation and
decreased Mtb burden in the lung

We then aimed to characterize the broader effects that decreased Iκκ2 expression in AMs
would have on pulmonary Mtb infection. To do this, we infected littermate and CD11c-cre
Iκκ2fl/fl mice with a low dose of aerosolized Mtb HN878. In line with the idea that Iκκ2
expression antagonizes M1 activation, we observed that CD11c-cre Iκκ2fl/fl mice were less
susceptible to Mtb than littermate controls at early time points (Figure 9A). Similarly, we
observed increased accumulation of lung resident AMs and mDCs (Figure 9B), and increased
recruitment of inflammatory neutrophils, monocytes, and RMs (Figure 9C). In support of this,
we observed heightened levels of most inflammatory cytokines and chemokines at 21 d.p.i.
(Figure 9D), and slightly increased inflammation in lung sections at baseline (left) and 21 d.p.i.
(right) (Figure 9E). Taken together, this heightened early inflammatory milieu likely drives
improved innate immune responses that at least partially contribute to the observed early
protection.
To further test this hypothesis, we examined effector functions of these innate cells using
expression of surface MHC-II, and our previously published airway labeling technique.113 We
observed that both AMs (left panel) and mDCs (right panel) had significantly higher expression
of MHC-II at baseline in CD11c-cre Iκκ2fl/fl mice, (Figure 9F) suggesting a “primed” capability
of these cells to present antigen even with abrogated Iκκ2. Furthermore, we observed increased
migration of AMs out of the airway by 21 d.p.i, as measured by the decreased proportion of
airway label positive cells over time in CD11c-cre Iκκ2fl/fl mice (Figure 9G). We found that at
baseline and 14 d.p.i., the majority of both AMs (left) and mDCs (right) from CD11c-cre Iκκ2fl/fl
mice were localized in the airway, as expected and previously demonstrated. However, by 21
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d.p.i., the relative proportion of AMs in the airway of CD11c-cre Iκκ2fl/fl mice had significantly
decreased when compared to littermate controls and previous time points. Airway localization of
mDCs in CD11c-cre Iκκ2fl/fl mice remained constant throughout all early time points. This trend
of increased AM migration from the airway around 21 d.p.i. was previously observed to correlate
with AM homing into forming granulomas,113 thus suggesting that Iκκ2 may directly inhibit this
function.
Increased migration to the airway was observed for recruited cell types, where we found
an increased proportion of airway label positive neutrophils (left), monocytes (center), and RMs
(right) both at baseline and over the early time course in CD11c-cre Iκκ2fl/fl mice (Figure 9H).
This “swapping” of AMs to the interstitium and neutrophils to the airway was previously
observed in our studies as part of the general course of Mtb infection and suggests that decreased
Iκκ2 in AMs and mDCs may lead to enhanced inflammatory responses within the lung tissue,
but not in the airway. Increased migration of AMs from the airway and neutrophils to the airway
may be indicative of specific immune functions or cellular interactions not yet characterized.
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Figure 9: Decreased Iκκ
κκ2
κκ in CD11c+ phagocytes drives early increased inflammation and decreased Mtb burden
in the lung. Littermate and CD11c-cre Iκκ2fl/fl mice were aerosol-infected with ~100 CFU of Mtb HN878 (n=5
mice/group, experimental replicates=3). A) Bacterial burden in the lung was determined by serial dilution plating at
indicated timepoints. B&C) Lung myeloid cell populations were enumerated in littermate and CD11c-cre Iκκ2fl/fl
HN878-infected mice using flow cytometry at baseline or indicated d.p.i. D) Whole lung tissue homogenates were
analyzed by cytokine multiplex for indicated cytokines at 21 d.p.i. E) Pulmonary histology was assessed on H&E
stained FFPE lung sections from uninfected baseline and 21 d.p.i. infected littermate and CD11c-cre Iκκ2fl/fl mice . F)
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Littermate and CD11c-cre Iκκ2fl/fl mice were aerosol-infected with ~100 CFU of Mtb HN878. (n=5 mice/group,
experimental replicates=3) The percentage of MHCII+ AMs (left) and mDCs (right) were determined by flow
cytometry. The percentage of (G) AMs (left) and mDCs (right) or (H) neutrophils (Neuts, left), monocytes (Monos,
middle), and recruited macrophages (RMs, right) stained positive with airway label CD45.2 was calculated at indicated
time points by flow cytometry. Littermate and CD11c-cre Iκκ2fl/fl mice groups (n≥5) at individual time points were
compared using Student’s t-test. Mean and standard deviation (SD) were plotted for each group at each indicated time
point. *p<0.05, **p<0.01, ***p<0.001.

3.2.3 Decreased Iκκ2 in CD11c+ phagocytes maintains global decreased Mtb burden,
increased inflammatory responses at later time points
To examine the long-term consequences of abrogated Iκκ2 activity in airway phagocytes,
we examined later time points in our in vivo Mtb infection model. We selected these time points
to be generally after the onset of adaptive immunity and granuloma formation.23,64 We observed
significantly decreased bacterial burden in the lungs of HN878-infected CD11c-cre Iκκ2fl/fl mice
at 60 d.p.i., though no significant differences were observed at 30 or 75 d.p.i. (Figure 10A). As
with the early time points, we observed general heightened inflammatory responses,
characterized by increased accumulation of inflammatory cell types, most notably at 60 d.p.i.
(Figure 10B&C). At 75 d.p.i, we observed a switch in our trends, where the littermate mice
yielded higher inflammatory cell accumulation compared to CD11c-cre Iκκ2fl/fl mice. We further
observed heightened levels of inflammatory cytokines and chemokines as before, and trends
toward increased inflammation in lung sections (Figure 10D-E).
To determine what consequences, if any, that decreased Iκκ2 expression in airway
phagocytes would have on adaptive immunity, we examined CD4+ and CD8+ T-cells at 75 d.p.i.
We found that CD11c-cre Iκκ2 fl/fl mice had decreased accumulation of CD3+ lymphocytes in
general, (Figure 10F) as well as decreased accumulation of activated CD4+ (Figure 10G,H) and
CD8+ T-cells (Figure 10J,K). Furthermore, less IFN-γ and IL-17 producing CD4+ (Figure 10I)
and CD8+ (Figure 10L) T-cells were observed in the lungs CD11c-cre Iκκ2fl/fl mice, thus
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suggesting dampened adaptive responses (Figure 10I,L). Taken together, these findings suggest
that abrogated Iκκ2 on airway phagocytes has significant effects on both short and long term
pulmonary immune responses, and that decreased Iκκ2 expression may detrimentally affect the
induction of adaptive immunity, while maintaining slight protection against pulmonary Mtb
infection.
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Figure 10: Decreased Iκκ
κκ2
κκ in CD11c+ phagocytes maintains global decreased Mtb burden, increased
inflammatory responses at later time points. A) Littermate and CD11c-cre Iκκ2fl/fl mice were aerosol-infected with
~100 CFU of Mtb HN878 (n=5-10 mice/group). Bacterial burden in the lung was determined by serial dilution plating
at indicated timepoints. B&C) Lung myeloid cell populations were enumerated in littermate and CD11c-cre Iκκ2fl/fl
HN878-infected mice using flow cytometry at baseline or indicated d.p.i. D) Whole lung tissue homogenates were
analyzed by cytokine multiplex for indicated cytokines at 60 d.p.i. E) Pulmonary histology was assessed on H&E
stained FFPE lung sections from 60 d.p.i. infected littermate and CD11c-cre Iκκ2fl/fl mice. F-L) Accumulation of (F)
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CD3+ lymphocytes, (G,H) CD4+ or (J,K) CD8+ T-cells expressing CD44 were determined at 75 d.p.i. by flow
cytometry (n=10). (I,L) Activated CD44hi CD4+ (I) or CD8+ (L) T-cells producing IFN-γ, IL-17 or both were
determined by flow cytometry. Littermate and CD11c-cre Iκκ2fl/fl mice groups (n≥5) at individual time points were
compared using Student’s t-test. Mean and standard deviation (SD) were plotted for each group at each indicated time
point. *p<0.05, **p<0.01, ***p<0.001.

3.3

Materials and Methods

Mice
C57BL/6J (B6) were purchased from The Jackson Laboratory (Bar Harbor, ME) and bred
in house. Itgax-cre (CD11c-cre) mice were a kind gift from the Virgin lab at WUSM and bred in
house. Iκκ2fl/fl (ikk2 fl/fl) were sourced and bred in house as previously described.113,298 All mice
were maintained in the animal facility at Washington University in St. Louis and bred in-house.
Experimental mice were age and sex matched and infected between the ages of 6 and 8 weeks.
All mice were maintained and used in accordance with the approved Washington University in
St. Louis Institutional Animal Care and Use Committee (IACUC) guidelines. Both male and
female mice were used and to our knowledge no sex-based differences were observed.

Mtb Strains and Experimental Infections
Mtb strains H37Rv (Trudeau Institute), and HN878 were obtained from BEI Resources
(Manassas, VA) under National Institutes of Health contract AI-75320 as previously
described.113 H37Rv-GFP and HN878-GFP were transformed with the integrating EGFP
expression vector pMV261.kan (provided by Dr. Christina Stallings, Washington University in
St. Louis) to generate GFP-expressing Mtb as previously described.113
Proskauer Beck medium supplemented with 0.05% Tween 80 and frozen at −80 °C while
in mid-log phase. Prior to infection, frozen stocks were thawed and placed in a solution of sterile
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PBS. Mice were aerosol-infected at tested low doses (~100 CFU) of indicated Mtb strains using a
Glas-col nebulizer.310 Mice were monitored and weighed as needed. At the indicated time points
mice were sacrificed via carbon dioxide narcosis and lungs and spleens were harvested. Mtb
CFU/organ was quantitated by plating 10-fold serial dilutions of homogenized lung or spleen
tissue on 7H11 agar plates (BD Biosciences, Franklin Lakes, NJ). Plates were incubated for 2–3
weeks at 37 °C and colonies were counted visually.

In Vitro Culture, Stimulation, and Infection
Mouse lung epithelial cell line C10 cells were cultured to confluence in 24 well plates in
complete Dulbecco’s modified eagle’s medium (cDMEM) to confluence for approximately 2
days. Prior to in vitro infection hemocytometer counts from a representative well were used to
calculate multiplicity of infection (MOI). C10 cells were washed once with sterile PBS and then
either stimulated or infected as described previously.113,192 Briefly, cells were either stimulated
with indicated conditioned media or infected with Mtb at an MOI of 1 in cDMEM without
antibiotics and in both cases incubated at 37°C, 7.5% CO2 for indicated time points. Supernatants
were collected and stored at −80°C. Cells were collected by tryspinization and stained as per
manufacturer's protocol.
Primary B6 mouse BMDMs and BMDCs were prepared as previously described.113,192,310
Briefly, bone marrow was harvested from the femur and tibia of B6 and gene deficient mice
were extracted, in a solution of serum free DMEM and then passed through a 70 μm screen, spun
down and then resuspended in red blood cell lysis solution. 1 × 107 cells were plated in 10 mL of
cDMEM supplemented with 3% (30 ng/mL) mouse recombinant (rm) granulocyte-macrophage
colony-stimulating factor (GM-CSF) (Peprotech, Rocky Hill, NJ) for ~7 days total at 37 °C in
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5% CO2.310 On day 3, cultures were supplemented with an additional 10 mL of cDMEM +
rmGM-CSF. At harvest, adherent cells were collected as BMDMs, and floating cells were
collected as BMDCs, gently washed with cDMEM via centrifugation (1,200 rpm, 6 min at 4°C),
resuspended and then plated at 1 × 106 cells per ml.
BMDMs, BMDCs, and C10 epithelial cells were infected with Mtb at indicated
multiplicity of infection (MOI) in antibiotic-free cDMEM. Cell culture supernatants were
collected for analysis of cytokines at indicated timepoints post infection.

Flow Cytometry
Flow cytometry was conducted on single cell preparations derived from infected and
uninfected lungs using fluorochrome conjugated antibodies. For distinguishing between airway
and non-airway cells, mice received 0.7 μg of BV605-conjugated CD45.2 mAb (Clone 104, BD
Biosciences and Biolegend, San Diego, CA), administered i.t. in 50 μL sterile PBS per mouse as
described previously.113 Mice were rested for 15 min following which lungs were harvested.
Lung single cell suspensions were prepared as before, 113,192,310 treated with Fc Block
(CD16/CD32, 2.4G2, Tonbo Biosciences, San Diego, CA), and stained with appropriate
fluorochrome-labeled specific antibodies or isotype control antibodies:
Myeloid antigen presenting cell panel:113,192 CD11b (M1/70, BD Biosciences and Tonbo
Biosciences), CD11c (HL3, BD Biosciences), Gr-1 (RB6-8C5, BD Biosciences), Siglec-F (E502440, BD Biosciences), Ly6G (1A8,BD Biosciences), Ly6C (AL-21,BD Biosciences), CD64
(X54-5/7.1,Biolegend), CX3CR1 (SA011F11, Biolegend), MHC-II (M5/114.15.2, Tonbo
Biosciences and eBiosciences).
Cells were defined as: AMs: CD11b−, CD11c+, Siglec-F+, CD64+, and/or Gr-1-. mDCs:
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CD11b+, CD11c+, MHC-II+. Neutrophils: CD11b+, CD11c−, Gr-1hi. Monocytes: CD11b+ CD11c−
Gr-1int and/or Ly6C+. Recruited macrophages: CD11b+ CD11c−, Gr-1lo, CD64+/−, Ly6C+/−,
MHC-II+/−.
Activated lymphocyte panel:21,172 CD3ε (500A2 or 145-2C11, Tonbo Biosciences), CD4
(GK1.5 or RM4-5, BD Biosciences), CD8α (53-6.7, BD Biosciences), CD44 (IM7, eBioscience),
IFN-γ (XMG1.2, BD Biosciences) and rat IgG1 (BD Biosciences).
Live, apoptotic, or dead cell panel:113 Annexin V (PE) and 7-AAD (PerCP-Cy5.5) from
the BD Pharmingen Apoptosis Detection kit were utilized and cell percentages were quantified
by flow cytometry as per manufacturer's suggested protocol (BD Biosciences). The percentage of
cells were defined as live (Annexin V−, 7-AAD−), apoptotic (Annexin V+, 7-AAD−), and dead
(Annexin V+, 7-AAD+).
Data collection and analysis were conducted on the BD LSR Fortessa, Fortessa-X20
Cytometers or the FACSJazz Cell Sorter, all with FACS Diva software and post-acquisition
analysis conducted on FlowJo.

Western Blotting
Western blot analysis to determine protein content was carried out as previously
described.346 Briefly, whole-cell extracts were prepared using radioimmunoprecipitation assay
(RIPA) cell lysis buffer supplemented with PMSF, and other protease and phosphatase
inhibitors. Samples were normalized for equal amounts of proteins using a Bicinchoninic acid
(BCA) protein assay kit (Thermofisher Scientific, Waltham, MA). Proteins were resolved by
electrophoresis on 10% SDS-PAGE and transferred to nitrocellulose membrane (Biorad,
Hercules, CA). Membranes were blocked with 5% nonfat milk in TBST buffer and incubated
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with Iκκβ (Iκκ2, ikk2) primary antibody (rabbit monoclonal Iκκβ antibody, Cell Signaling
Technology, Danvers, MA; 1:500) or the loading control antibody (rabbit polyclonal Gapdh,
Thermofisher scientific; 1:1000) overnight at 4C. Peroxidase-conjugated goat anti-rabbit IgG
(ThermoFisher Scientific; 1:10,000 ) was used as a secondary antibody and protein detection was
accomplished using the Pierce ECL western blotting detection kit (Thermofisher Scientific).
Densitometry was performed on scanned western blots using ImageJ software (NIH, Bethesda,
Maryland). The results presented are the mean Iκκβ (Iκκ2) band intensity, relative to control
Gapdh band intensity.

Histology
All histological processing, visualization and analysis was performed as previously
described.113,192 Briefly, lung lobes were perfused with 10% neutral buffered formalin and
embedded in paraffin. For immunofluorescent staining, formalin-fixed paraffin-embedded
(FFPE) lung sections were cut, immersed in xylene to remove paraffin, and then sequentially
hydrated in absolute ethanol, 95% ethanol, 70% ethanol, and water. Antigens were unmasked
with a DakoCytomation Target Retrieval Solution (Dako, Carpinteria, CA) and nonspecific
binding was blocked with 5% (v/v) normal donkey serum and Fc Block (BD Pharmingen, San
Jose, CA). Endogenous biotin (Sigma-Aldrich) was neutralized by adding avidin followed by
incubation with biotin.
For inflammatory quantification, FFPE lung sections were stained with hematoxylin and
eosin (H&E) and inflammatory features/pathology were evaluated by light microscopy. Features
were assessed digitally using the automated tool of the Zeiss Axioplan 2 microscope (Carl Zeiss)
of H&E stained slides to quantify inflammation and immunofluorescence labeled slides B220,
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CD3 and counter stained with DAPI in order to assess lymphoid follicle area.

Cytokine Production Quantification
Cytokine/chemokine production was analyzed in lung homogenates from infected mice
or cell culture supernatants via Luminex Multiplex assays (Millipore-Sigma) or indicated ELISA
(R&D) as per standard protocol.

Statistical Analysis
Data analysis was conducted in GraphPad Prism 5 (La Jolla, CA) using unpaired two
tailed Student's t-test for comparison between two groups or one-way analysis of variance for
multiple comparisons. Significance is denoted as: *p < 0.05, **p < 0.01, ***p < 0.001, not
detected, ND.

3.4

Discussion and Conclusions

Even though Mtb is the leading cause of infectious disease related deaths worldwide, the
initial steps in preventing establishment of pulmonary infection remain poorly understood. A
large body of evidence suggests that the innate immune system has the capacity to entirely clear
Mtb infection in some individuals prior to onset of adaptive immunity.24,25 Furthermore, recent
work to characterize host correlates of protection has implicated innate immunity and early
inflammatory responses in the conserved protective response across species.11,12,14,15,347 Despite
this strong evidence in support of early clearance by innate immunity, determining the concise
role airway resident AMs and mDCs play in these responses has proven difficult. Depletion of
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AMs and mDCs by clodronate liposomes yielded improved disease outcomes during Mtb
infection, as marked by improved T-cell priming,100 and decreased pulmonary inflammation,
gross lung damage, and total Mtb burden.96 In other studies, transient DTR depletion of AMs and
mDCs yielded exacerbated inflammation and more severe Mtb burden.98,99,103-105 These mixed
findings reflect the complex nature of balancing inflammation during pulmonary infection, and
suggest multiple roles for macrophages during pulmonary infection depending on context.
In this study, we sought to concisely isolate and characterize the contrasting roles of AMs
during Mtb infection. In previous work we and others found that non-airway localized AMs
highly upregulated genes and pathways associated with M1 functions and NF-κB
activation.113,126 We therefore aimed to separate early M1/M2 macrophage polarization and
effector functions by targeting NF-κB activation. Furthermore, we sought to determine how these
effector roles skew disease severity and mediate both short- and long-term protective responses.
In order to model these distinct airway and non-airway signatures, we developed a mouse model
targeting Iκκ2 of the NF-κB complex in CD11c expressing AMs and mDCs.
Using this CD11c-cre Iκκ2fl/fl mouse model to abrogate Iκκ2 in airway phagocytes, we
aimed to separate the airway and non-airway phenotypes to concisely determine their
contributions to early protective immunity. We found that decreased Iκκ2 activity drove
increased inflammatory cytokine production in isolated CD11c+ cells. We observed this same
hyperinflammatory phenotype at early time points during in vivo Mtb infection, which were
marked by increased production of inflammatory cytokines and accumulation of innate immune
cells at all time points prior to granuloma formation. Indeed, previous studies show a role for
Iκκ2 in antagonizing M1 activation,139,140 and inhibition of NF-κB improves Mtb killing in vitro
in human macrophages.138 Protective M1 roles are generally attributed to monocyte derived
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macrophages recruited from the bone marrow, and AMs are generally regarded as
permissive.67,89,109 Our findings suggest that the CD11c-cre Iκκ2fl/fl model may yield prepolarized M1 AMs and may be a suitable model for understanding protective early pulmonary
responses.
When examining CD11c-cre Iκκ2fl/fl mice in vivo, we observed a mixture of phenotypes
when compared to the aforementioned depletion models. We found CD11c-cre Iκκ2fl/fl mice to
yield decreased Mtb burden but increased inflammatory responses and decreased T-cell priming.
The differences observed in our model compared to these previous studies are likely due to
heightened pro-inflammatory responses driven by NF-κB/Iκκ2 inhibition, which skews towards
M1 polarization. While increased M1 polarization yields direct improved killing of Mtb by
macrophages, it also drives overt inflammation and tissue damage.139 Furthermore, the
timing/nature of depletion and the strain of Mtb used likely affects the differential overall
outcomes observed.
We found that this hyperinflammation correlated with protection and decreased Mtb
bacterial burden at most time points examined, even after granuloma formation and induction of
adaptive immunity. It is important to note that genetic knockout mouse models rarely yield
protective phenotypes during pulmonary Mtb infection,11,348,349 making these findings
noteworthy. We found that even at later time points after induction of adaptive immunity, the
hyperinflammatory effects of our model were still maintained. We found increased accumulation
of innate immune cells and inflammatory cytokines around the time of granuloma formation, as
well as later time points.
When we examined recruited lymphocytes, we shockingly observed decreased
accumulation of activated CD4+ and CD8+ T-cells at 75 d.p.i. This was contrary to our
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hypothesis, as we expected that heightened M1 activity in the model would drive improved Tcell interactions and therefore improved adaptive immunity. It is possible that decreased Mtb
burden across time points can explain the abrogated T-cell responses we observed. It is also
likely that differential effects of the CD11c-cre Iκκ2fl/fl model separately on AMs and mDCs
could also play a significant role. While this model drives improved M1 polarization of AMs, it
is likely that abrogation of NF-κB in DCs affects cellular migration137 and expression of
costimulatory markers,350,351 thus abrogating T-cell priming and activation. Indeed, we observed
that around half of mDCs remained in the airway through 21 d.p.i. in CD11c-cre Iκκ2fl/fl mice,
which was significantly higher than littermate controls. Future work will attempt to further
isolate the distinct roles of AMs and mDCs with more specific targeting, so as to prevent
confounding effects such as these.
Many factors can alter macrophage phenotype and effector function, suggesting that the
M1/M2 dogma should be redefined as more of a spectrum of responses across various
contexts.123,124 Recent findings demonstrate that cellular microenvironment and inflammatory
milieu play a key role in determining macrophage polarization, and the timing, context, location,
and magnitude of M1/M2 responses can determine overall outcomes.20,51 taken with previous
work, these findings suggest that AMs may play protective roles in some contexts,25,26 and may
not always be permissive as previously thought. Our work further highlights a key role for AM
inflammatory signaling throughout infection, not just at the onset of pathogenesis. These data
suggest that AMs contribute to host responses and have broad effects on inflammation and host
defense, even well after the onset of adaptive immunity. These findings have key implications
for our knowledge of bridging innate and adaptive responses and provide support for directing
preventative strategies at pulmonary innate immunity.
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Taken together, this study suggests that targeting Iκκ2 as a therapeutic approach may
have protective effects during pulmonary Mtb infection. As reliable drugs are already available
to researchers for targeting and abrogating Iκκ2 activity, this approach may prove a promising
strategy for priming innate immunity to entirely prevent Mtb establishment and infection.
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Chapter 4: Examining the role of Mtbspecific lipid factors in modulating early lung
immune interactions and long-term
susceptibility
This chapter is excerpted from the following manuscript:
Dunlap & Prince et al. Formation of lung inducible Bronchus Associated Lymphoid Tissue is
regulated by Mycobacterium tuberculosis expressed determinants. Front Immunol. (2020)
PMID: 31010841
Please refer to the above publication for supplemental data referenced in this chapter
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4.1

Introduction
The first interactions between Mtb and the host happen in the lung airways immediately

after inhalation of Mtb bacilli. These early interactions involve AMs,352 DCs,103,353 and AECs
lining the airway35,60 and have the potential to drive immune responses. As a result of initiation
of immune responses, the tubercle granuloma is formed, which is a hallmark immune structure
formed during TB.179 We have previously shown that protective granulomas that are formed
during latent TB are associated with the formation of B-cell containing lymphoid follicles.172
During severe ATB, granulomas that do not effectively contain Mtb are comprised
predominantly of neutrophils190,191 and permissive monocytes,354 which have been implicated in
general tissue destruction, thus skewing responses toward disease progression. Non-protective
granulomas are hallmarked by the formation of hypoxic, necrotic cores that do not prevent Mtb
growth and eventually lead to dissemination to other organs and tissues.191 The earliest
mechanism(s) which determine the nature and outcome of granulomas during infection remains
elusive, and are a focus of this work.
In this study, we aimed to determine the Mtb and host specific factors that drive the
formation of iBALT during TB. To examine the Mtb specific factors involved, we utilized an
Mtb transposon mutant library to screen the induction of lymphoid follicles using the NonHuman Primate (NHP) model of pulmonary TB. This screen allowed us to identify Mtb genes
which when mutated led to increased induction of iBALT within granulomas. The NHP model
exhibits characteristics associated with human TB including the pulmonary cellular and acellular
lesions.355-357 We found an over-representation of Mtb cell wall mutants within iBALT
containing granulomas and further characterized the role of one such mutant using the mouse
model of TB. The Mmpl7 inner membrane protein is best known for the transport of PDIM to the
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free fatty acid layer of the MOM.226,227 The role of lipid presentation in the MOM is welldocumented in modulating various host responses,265,266,358 suggesting that MOM lipids contact
with host cells in the lung plays a role in disease progression.
In light of these observations, we aimed to understand how the Mtb Δmmpl7 cell wall
mutant identified in our screen modulates early epithelial signaling and myeloid recruitment in
order to coordinate granuloma structure and the formation of iBALT. In this study we found that
in the mouse model, infection with the Δmmpl7 mutant drives decreased bacterial burden and
increased formation of iBALT, as was observed in NHPs. Furthermore, the Δmmpl7 mutant also
drove decreased inflammatory cytokine and chemokine production in vitro and in vivo, along
with decreased accumulation of myeloid and lymphoid immune cells. We demonstrate that the
Δmmpl7 mutant overexpresses diacyl trehaloses (DATs), a Mtb cell wall lipid, which can drive
the observed decreased inflammatory cytokines and chemokine production by in vitro
macrophages and also yields increased production of IL-10.

4.2

Results

4.2.1

Identification of Mtb genes associated with formation of protective lymphoid follicles

TB granulomas contain distinct iBALT structures which are protective in mice and
macaques.23,172 NHPs infected with Mtb exhibit the spectrum of disease severity observed
clinically during human TB, with a diverse array of granuloma structures reflected by differences
in immune cell recruitment and disease outcome.355,356 Thus, we used the NHP model to probe
the early host-Mtb interactions that mediate the signaling events that initiate the induction of
iBALT within TB granulomas. NHPs were infected with 1x105 CFU of Mtb (H37Rv) mutants
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from the himar1 transposon mutagenesis site hybridization (TraSH) library.359,360 Four to six
weeks post-infection, the animals were humanely euthanized due to TB disease. At this time,
macaque lungs demonstrated a wide distribution of caseous and follicular granulomatous
structures (Figure 11), with follicular granulomas featuring prominent cellular structure. In
combination with mesodissection, DNA sequencing analysis of separate B cell follicle
containing granulomas, seeded by Mtb mutants,361,362 identified nine Mtb single mutants that
were highly represented within distinct iBALT containing TB granulomas in macaques (Figure
11 and Table 4). Of the Mtb mutants represented within these “protective” granulomas, two
members of the mycobacterial membrane protein large family (Mmpl2 and Mmpl7), were well
reflected. Mmpl2 is a putative inner membrane transporter protein with unknown substrate, while
Mmpl7 is an inner membrane protein associated with PDIM transport to the MOM.226,227 The
NAD dehydrogenase, NdhA is a nonessential protein found in the inner mycobacterial membrane
associated with NADH mediated electron transfer to the electron transport chain.363 EccD5 is an
essential inner membrane protein that makes up part of the type VII secretion system, the
absence of which results in sensitivity to detergents and killing by macrophage.364 ClpB and Acr2
are both heat stress molecular chaperones regulated by the alternative sigma factors SigH and
SigE, respectively.365 Of the two, only ClpB is essential for in vitro growth. The non-redundant
glutamine synthetases GlnA2 and GlnA4 are involved in nitrogen metabolism but are not
associated with any loss of virulence in vivo.366 Cmtr is a cytosolic sensor of cadmium Cd(II) and
lead Pb(II)367,368 which are trace metal contaminants found in the lung (Table 4).
Taken together, the Mtb transposon screen conducted in NHPs has identified a novel set
of Mtb genes involved in generation of lymphoid follicles within the lung, that appear to control
Mtb metabolism and inner membrane lipid transport. In this study, we chose to mainly focus on
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the interaction driven by Mtb Mmpl7 that mediates formation of the granuloma.

Table 4: Identification of Mtb genes associated with formation of protective lymphoid follicles. Transposon site
hybridization library (TraSH) using the himar1 transposon mutagenesis strategy was employed to create a Mtb mutant
library for the specific discovery of Mtb genes influencing the progression of lymphoid follicle containing granulomas
in NHPs. NHPs were infected with 1x105 CFU of Mtb H37Rv mutants and lung sections were harvested 4-6 weeks
after infection. In combination with mesodissection, the analysis of >1,200 lesions identified 9 Mtb mutants that were
highly represented within protective iBALT containing TB granulomas in macaques. *=essential gene.
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Figure 11: Identification of Mtb genes associated with formation of protective lymphoid follicles. Transposon
site hybridization library (TraSH) using the himar1 transposon mutagenesis strategy was employed to create a Mtb
mutant library for the specific discovery of Mtb genes influencing the progression of lymphoid follicle containing
granulomas in NHPs. NHPs were infected with 100,000 CFU of Mtb mutants and lung sections were harvested 4-6
weeks after infection. In combination with mesodissection, the analysis of >1200 separate lesions identified nine Mtb
single mutants that were highly represented within protective iBALT containing TB granulomas in macaques. Single
Mtb mutants were isolated from single granulomas.

4.2.2 Δmmpl7 mutant drives Mtb enhanced B cell follicle containing iBALT formation in the
mouse model
To determine the functional role of Mtb Mmpl7 in modulating iBALT generation in vivo,
we infected B6 with 100 CFU Mtb Erdman or the Δmmpl7 mutant Erdman strain and
characterized immune recruitment and induction of iBALT features in the lung. As previously
shown, infection with the Δmmpl7 mutant resulted in early decreased Mtb CFU which recovered
by 40 d.p.i. in the lung and spleen (Figure 12A). At a time when Mtb CFU was comparable
between the WT and mutant strains, we observed that the total inflammation observed in the
lungs of the Δmmpl7 mutant infected mice was significantly decreased (Figure 12B-C).
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However, despite significantly decreased overall inflammation, infection with the Δmmpl7
mutant resulted in increased formation of B cell lymphoid follicle containing area, reflecting
iBALT areas (Figure 12D-E). Furthermore, by 40 d.p.i., T-cells were well able to infiltrate
within iBALT containing granulomas, as the area of T cell cuffing around the granulomas was
decreased in Δmmpl7 mutant infected mice (Figure 12D-E). Together, these findings suggest
that Mtb lacking the Mmpl7 gene induces improved induction of iBALT and decreased
inflammation, suggesting that Mtb actively shuts down iBALT formation utilizing virulence
factors such as PDIM, or alternatively, the reduced early Mtb growth in the Mmpl7 mutant in
vivo propagates iBALT containing granulomas.
It has been shown previously that the Δmmpl7 mutant lacks the ability to transport
PDIMs, an important Mtb structural lipid and virulence factor, to the MOM, leading to an early
growth defect in vivo when mice are infected intravenously.226,227 Thus, to specifically address if
the early decrease in Mtb CFU burden in the mutant infection was responsible for increased
iBALT formation, we infected mice with a 5-fold higher dose (500 CFU) of Mtb Δmmpl7 to
directly compare the ability of Δmmpl7 mutant to induce iBALT when compared to low dose
(100 CFU) infection with wildtype (WT) Mtb Erdman (Supplemental Figure 6, Appendix).
Using the higher dose model, our data show that Δmmpl7 mutant still had early defects in Mtb
CFU in vivo in the lung and spleen as previously shown, but at 40 d.p.i. showed comparable
CFU to WT Mtb and similar overall inflammation (Supplemental Figure 6A-B, Appendix).
Importantly, the higher dose model maintained the observed increased iBALT formation
(Supplemental Figure 6C, Appendix). Whether this phenotype was due partially or entirely to
the lack of PDIMs on the MOM or due to other changes in the Δmmpl7 mutant was further
evaluated in this study.
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Furthermore, by 40 d.p.i., no differences in bacterial burden were observed in the lung or
spleen between WT Erdman and Δmmpl7 mutant, which is more likely due to increased control
of WT Erdman while Δmmpl7 mutant CFU levels were maintained. These findings demonstrate
that our 5-fold higher CFU dose aerosol infection used to compensate for the growth defect in
the Δmmpl7 mutant still recapitulates the in vivo phenotype observed with low dose infection.
These data suggest that the observed phenotype of increased iBALT formation in the Δmmpl7
mutant infection is likely not an artifact of abrogated Mtb growth.
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Figure 12: Δmmpl7 mutant drives Mtb enhanced B cell follicle formation in mouse model. Sex and age matched
C57BL/6 mice were infected with 100 CFU of Mtb Erdman WT or Δmmpl7. A) Lung and spleen homogenates were
used to determine Mtb CFU counts at indicated time points. B-C) Lungs from Mtb-infected mice at 20 (top) and 40
(bottom) d.p.i. were formalin fixed, embedded in paraffin and used for H&E staining and inflammation was quantified
by tracing areas. D-E) B cell follicles present within lung sections were visualized by confocal microscopy. Slides
were visualized and quantified by outlining the lesions using the automated tool of the Zeiss Axioplan 2 microscope.
Infected groups (n≥5) comparing WT Erdman and Δmmpl7 Mtb strains at individual time points were compared using
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Student’s t-test. Mean and standard deviation (SD) were plotted for each group at each indicated time point. *p<0.05,
**p<0.01, ***p<0.001.

4.2.3

Δmmpl7 mutant Mtb limits early myeloid cell accumulation in the Mtb-infected lung
To examine the early immune events that occur in the lung that mediate differences in

iBALT formation, we infected mice with 100 CFU wildtype Mtb Erdman or 5-fold higher CFU
(500 CFU) of the Δmmpl7 mutant and characterized myeloid and T cell accumulation in the lung.
Upon infection with the Δmmpl7 mutant, we observed decreased neutrophils, monocytes and
RMs at early time points as well as decreased accumulation of AMs and mDCs when compared
with accumulation in WT Mtb infected lungs (Figure 13A-B). We saw similar decreases in
accumulation of total CD3+ T-cells (Figure 13C), activated and IFN-γ producing CD4+ (Figure
13D) and CD8+ T-cells (Figure 13E) at later time points.
These cellular changes coincided with early decreased production of inflammatory
cytokines, such as IL-6, G-CSF and IL-17, and chemokines, such as MIP-2 (CXCL2), and IP-10
(CXCL10) that are associated with myeloid recruitment in Mtb Δmmpl7 infected mice, (Figure
13F-J). Interestingly, this coincided with an early increased induction of IL-10 at 15 d.p.i.,
though this effect was abolished by the later time points (Figure 13K). As IL-10 is a known
mediator of anti-inflammatory responses,162,369 these findings suggest a potential mechanism for
the decrease in pro-inflammatory cytokines and lung inflammation. Taken together, these data
demonstrate an overall “dampening” of the immune response during early infection with the
Δmmpl7 mutant, suggesting that decreased inflammation and decreased neutrophilia may
improve the formation of protective iBALT containing granulomas, thus improving TB disease.
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Figure 13: Δmmpl7 mutant Mtb limits myeloid cell accumulation in the lung. Sex and age matched C57BL/6 mice
were infected with 100 CFU Mtb Erdman WT or 500 CFU Δmmpl7. Single cell suspensions were processed from
infected lungs and immune cell subsets were analyzed by flow cytometry. A) tissue resident myeloid and B) recruited
myeloid cell accumulation in the Mtb-infected lungs was determined at indicated time points. C) CD3+ lymphocytes,
D) CD4+ or E) CD8+ T-cells were determined using flow cytometry. F-K) Protein levels of inflammatory cytokine
and chemokines IL-6, G-CSF, MIP-2(CXCL2), IL-17, IP-10 (CXCL10), and IL-10 were determined in lung
homogenates at indicated time points. Infected groups (n=5) comparing WT Erdman and Δmmpl7 Mtb strains at
individual time points were compared using Student’s t-test. Individual time points within the same group were
compared using 2-way ANOVA with Bonferroni post-tests. Mean and standard deviation (SD) were plotted for each
group at each indicated time point. *p<0.05, **p<0.01, ***p<0.001.
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4.2.4 Δmmpl7 mutant Mtb overexpresses DATs and limits cytokine production in lung
epithelial cells
Having observed abrogated recruitment of myeloid cells after infection with the Mtb
Δmmpl7 mutant and decreased cytokine/chemokine production in vivo (Figure 13), we
hypothesized that the Δmmpl7 mutant was specifically modulating inflammatory molecule
production and subsequent recruitment of immune cells. Increased early IL-10 production and
decreased neutrophilia and inflammation observed after infection with the Δmmpl7 mutant likely
skewed the immune response towards protective iBALT containing granulomas. Alternatively,
increased neutrophil accumulation and increased pro-inflammatory cytokines, including G-CSF
and IL-6, are induced in response to WT Mtb infection and drive non-protective, necrotic
granulomas.190,191,370
To address if G-CSF was a marker of ATB disease in humans, we measured levels in
individuals with ATB or LTBI in two human cohorts. We observed that G-CSF production was
increased in ATB individuals when compared with LTBI or house contacts (HCs) (Figure 14A).
Furthermore, it was previously demonstrated that individuals with ATB also have increased
serum levels of IL-6.371,372 As such, both G-CSF and IL-6 were used as cytokine indicators of
inflammatory response severity for the remainder of this study.
To further test this hypothesis in our model, we examined mouse lung epithelial cells in
vitro, which are a key source of G-CSF, and other inflammatory cytokines in the context of lung
infection.34-36,52,60,190,299,373 We assayed epithelial cell derived G-CSF production in vitro after
infection with either WT Mtb Erdman or Δmmpl7 mutant. Firstly, we found that epithelial cells
infected with WT Mtb induced significant G-CSF in a time-dependent manner. In contrast,
infection of epithelial cells with Δmmpl7 mutant resulted in significantly decreased G-CSF
production when compared to WT Erdman infection (Figure 14B). When performing
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coinfection with varying ratios of WT Erdman and Δmmpl7 mutant, we observed that even 3
times the presence of WT Mtb did not reverse the abrogated G-CSF production observed upon
Δmmpl7 mutant infection (Figure 14C). Furthermore, we observed a significant decrease in GCSF production even when WT Erdman infected epithelial cells were co-administered heatkilled (HK) Δmmpl7 mutant, suggesting that the inhibition of G-CSF was dependent on a factor
expressed by Mtb Δmmpl7 and did not depend on the viability or infectivity of the bacteria
(Figure 14D). These data together suggest that a molecular factor present in the Δmmpl7 mutant
is likely limiting G-CSF expression in vitro and in vivo.
From these data, we hypothesized that a lack of Mmpl7 in Mtb led to changes in the lipid
profile of the MOM beyond the reported loss of PDIMs,226,227,268 thus inducing the presence of
other lipids and virulence factors than those present on WT Mtb Erdman.201,374 We hypothesized
that these lipids may decrease the production of G-CSF, IL-6 and other inflammatory cytokines,
thus driving decreased myeloid recruitment and increased iBALT formation upon infection. To
test this, we freshly grew Mtb WT and Δmmpl7 mutant bacteria three independent times,
normalized by bacteria weight, and extracted and characterized their total lipid content by 1 and
2 dimensional thin layer chromatography (1D or 2D TLC) (Figure 14E and Supplemental
Figure 7, Appendix), using different solvents systems allowing us to fully screen the wide range
of lipids present on the mycobacterial cell envelope. We found that while SLs, TDMs, and
TMMs were present at similar levels, DATs were expressed at higher levels in the cell envelope
of the Δmmpl7 mutant Mtb (11.5% of total lipid) when compared to WT Erdman (6.8% of total
lipid) (Figure 14E and Supplemental Figure 7, Appendix, black arrows). DATs are
heterogeneous glycolipids (>30 molecular species described) composed of a trehalose sugar
structure with two acyl chains, where the trehalose moiety is thought to bind to the macrophage109

inducible C-type lectin Mincle.262-264 DATs have been previously shown to negatively regulate
the pro-inflammatory response of the host, thus promoting Mtb survival.265,266 Thus, these
findings suggested that increased presence of DATs in the Δmmpl7 mutant could be linked to the
decreased production of inflammatory molecules like G-CSF and IL-6 and the dampened
pulmonary inflammatory response observed in vitro and in vivo.265
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Figure 14: Δmmpl7 mutant Mtb overexpresses DATs and limits cytokine production in lung epithelial cells. A)
Serum samples from human active TB patients and controls (Left Panel: Mexico (TB- n=30; ATB n=13; LTB n=33),
Right Panel: South Africa (ATB n=30; LTB n=20) were analyzed for G-CSF levels. Mouse lung epithelial cells (n≥4
per group) were infected with Mtb Erdman WT or Δmmpl7 at B) MOI=1 or MOI=5, respectively, for indicated time
points. C) Mouse lung epithelial cells (n=4) were infected with Mtb Erdman WT and/or Δmmpl7 at indicated ratios
for a constant total MOI=1. D) Mouse lung epithelial cells (n=4) were infected with Mtb Erdman WT with or without
the addition of heat-killed (HK) Δmmpl7. A-D) Supernatants were collected and G-CSF concentration was quantified
by ELISA. E) Total lipids from Mtb Erdman WT or Δmmpl7 were obtained from freshly grown bacteria (3 independent
times) and extracted with chloroform:methanol (2:1, v/v/) after normalization by total bacterial number. Total lipids
(100 mg) were analyzed by TLC using as a solvent system (chloroform:methanol:water, 90:10:1, v/v/v) and 10%
sulfuric acid in ethanol as a developer to visualize total lipid contents (representative experiment shown).
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Densitometry analyses of the observed lipids were performed using the NIH software ImageJ, n=3 (where each value
corresponds to independent extractions from freshly grown bacteria and TLCs). Human cohort study groups were
compared by 1-way ANOVA with Tukey’s post-test, or unpaired Student’s t-test, respectively. Infected groups
comparing WT Erdman and Δmmpl7 Mtb strains under indicated conditions at individual time points were compared
using 1-way ANOVA with Tukey’s post-test or unpaired Student’s t-test. TLC densitometry was analyzed by unpaired
Student’s t-test. *p<0.05, **p<0.01, ***p<0.001.

4.2.5 DAT administration drives decreased inflammatory molecule production in epithelial and
myeloid cells.
We next hypothesized that the increased expression of DATs could abrogate production
of cytokines, especially G-CSF, in epithelial cells,60,375 similar to what we observed with
infection with the Δmmpl7 mutant. To demonstrate this, we infected lung epithelial cells with
Mtb Erdman and co-treated them with DATs. Our results show that co-treatment with DATs
limited the production of G-CSF and IL-6 by WT Mtb infected epithelial cells (Figure 15A),
similar to the responses observed when Δmmpl7 mutant single infection and coinfections were
carried out (Figure 14). Additionally, the inhibitory effect observed was dose dependent, thus
confirming that the overexpression of DATs was one factor that was skewing the induction of
cytokines upon infection with the Δmmpl7 mutant. This effect was likely not due to DATinduced cell death, as levels of total live, apoptotic, and dead cells were only slightly altered after
addition of DATs (Supplemental Figure 8A, Appendix). IL-10 production within this culture
was below the limits of detection of the assay for all groups, even with addition of DATs, thus
suggesting that epithelial cells are likely not a significant source of anti-inflammatory signals in
this phenomenon.
We next aimed to determine if this phenotype was specific to epithelial cells or if the
Δmmpl7 mutant also regulated cytokine expression in myeloid phagocytes, and if the presence of
DATs modulated these responses as previously shown.265 Therefore, we infected macrophages
and DCs with WT and Δmmpl7 mutant (Figure 15B-E). We found that while Δmmpl7 mutant
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abrogated IL-1β and IL-6 expression in both macrophages and DCs (Figure 15C,E), the Δmmpl7
mutant surprisingly induced increased IL-10 expression in both cell types when compared to WT
Mtb (Figure 15B,D). Furthermore, no differences in cell death were observed between WT Mtb
and the Δmmpl7 mutant (Supplemental Figure 8B-C, Appendix), thus suggesting that this
finding is due to specific regulation of cytokine production, not apoptosis induced abrogation.
The decreased production of IL-1β and IL-6 in phagocytes was likely not only due to active
inhibition by DAT alone, as co-treatment with DAT-coated beads did not decrease production of
these cytokines during WT infection when compared to control beads. However, in BMDMs the
increased induction of IL-10 driven by the Δmmpl7 mutant Mtb over WT Erdman was
recapitulated by addition of DATs to WT Erdman infection (Figure 15B), thus suggesting that
DAT overexpression on Δmmpl7 mutant Mtb actively induced expression of anti-inflammatory
IL-10 produced by macrophages. The increased production of anti-inflammatory IL-10 by lung
macrophages may explain the early increased IL-10 observed in vivo in lung homogenates. These
early anti-inflammatory signals may abrogate the production of inflammatory cytokines and
pulmonary neutrophilia, thus skewing the immune response away from neutrophil rich, nonprotective granulomas, and towards iBALT containing protective granulomas.
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Figure 15: DAT administration drives decreased inflammatory molecule production in epithelial and myeloid
cells. A) Mouse lung epithelial cells (n=5) were infected with Mtb Erdman WT with or without the addition of raw
DATs at MOI=1 for 6 days. Mouse bone-marrow derived B-C) macrophages (BMDMs) (n=5) or D-E) dendritic cells
(BMDCs) (n=5) were infected with Mtb Erdman WT with or without the addition of DAT coated agarose beads, or
Δmmpl7 for 3 days. Supernatants were collected and the concentrations of cytokines G-CSF, IL-6, IL-1β and IL-10
were quantified by multiplex assays. Multiple groups were compared by 1-way ANOVA with Tukey’s post-tests.
*p<0.05, **p<0.01, ***p<0.001.
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4.3

Materials and Methods

Non-Human Primate Infection
An Mtb (H37Rv) transposon site hybridization mutants (TraSH) library (kind gift of Dr.
Chris Sassetti) was delivered high dose (≥100,000) CFU via bronchoscopic procedure into the
lungs of triplicate Indian rhesus macaques. Delivery of bacteria to the lower lungs was confirmed
via dilution plating and Mtb infection was confirmed by direct observation of the clinical signs of
TB and concurrent positive tuberculin skin test. NHPs were humanely euthanized after being
held 4–6 weeks due to development of disease using prespecified criteria.187,376,377 Lungs from
infected animals were harvested and processed for mesodissection as previously described.378,379
Briefly, lung sections were removed, formalin fixed and paraffin embedded. A series of
unstained and H&E slides were then made and used with the mesodissection instrument and 2iD
Imaging software. The H&E guide slide is used to direct the consumable mill bit to dissect the
unstained slide and harvest the nuclear material for downstream upscaling and identification. By
staining of B cells, iBALT associated lesions were first identified. The appropriate sections from
H&E slides were then dissected and used for sequencing as previously described380 to identify
the single Mtb mutant associated with each individual lesion.361,362
Mice
B6 mice used were 6–8 weeks old and sex matched. All treatments and conditions used to
handle study animals are in accordance with the approved Institutional Animal Care and Use
Committee (IACUC) guidelines at Washington University in St. Louis.
Bacterial Strains, Infection and Instillation
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Mtb (Erdman) and Δmmpl7 mutant (MJM39)226 were stocked in Proskauer-Beck with
0.05% tween 80 and stored at −80°C. Prior to infection, frozen stocks were thawed and placed in
a solution of sterile PBS for loading into the Glas-col nebulizer. Mice were infected with
aerosolized Mtb in the above Glas-col nebulizer at tested doses of ~100 CFU (low) or ~500 CFU
(5-fold higher) of Mtb per mouse. At the indicated time points mice were sacrificed via carbon
dioxide narcosis and lungs and spleens were harvested.
Microscopy and Inflammation, B Cell Quantification
Lung pathology from formalin fixed paraffin embedded lungs was assessed digitally
using the automated tool of the Zeiss Axioplan 2 microscope (Carl Zeiss) of H&E stained slides
to quantify inflammation and immunofluorescence labeled slides B220, CD3 and counter stained
with DAPI in order to assess lymphoid follicle area.
Bacterial Culture and Cytokine Analysis
Bacterial burden was assessed using serial 10-fold dilutions of lung or spleen and plated
on 7H11 supplemented with OADC (oleic acid, bovine albumin, dextrose, and catalase). After
2–3 weeks incubation colonies were counted visually. Cytokine/chemokine expression was
analyzed in lung homogenates from infected mice via Luminex (Millipore-Sigma) or ELISA
(R&D).
Flow Cytometry
Flow cytometry was conducted on single cell preparations derived from infected and
uninfected lungs using fluorochrome conjugated antibodies:
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Myeloid antigen presenting cell panel113 : CD11b (M1/70), CD11c (HL3), Gr-1 (RB6-8C5),
Siglec-F (E50-2440), Ly6G (1A8), Ly6C (AL-21), CD64 (X54-5/7.1), MHC-II (M5/114.15.2).
Cells were defined as: AMs: CD11b−, CD11c+, Siglec-F+, CD64+. mDCs: CD11b+CD11c+,
MHC-II+. Neutrophils: CD11b+, CD11c−, Gr-1hi. Monocytes: CD11b+ CD11c− Gr-1int and/or
Ly6C+. Recruited macrophages: CD11b+ CD11c−, Gr-1lo, CD64+/−, Ly6C+/−, MHC-II+/−.
Activated lymphocyte panel21,172: CD3ε (500A2), CD4 (RM4-5), CB8α (53-6.7), CD44 (IM7),
IFN-γ (XMG1.2).
Live, apoptotic, or dead cell panel113: Annexin V (PE) and 7-AAD (PerCP-Cy5.5) from the BD
Pharmingen Apoptosis Detection kit were utilized and cell percentages were quantified by flow
cytometry as per manufacturer's suggested protocol (BD Biosciences). The percentage of cells
were defined as live (Annexin V−, 7-AAD−), apoptotic (Annexin V+, 7-AAD−), and dead
(Annexin V+, 7-AAD+).
Data collection and analysis were conducted on the BD LSR Fortessa, Fortessa-X20
Cytometers or the FACSJazz Cell Sorter, all with FACS Diva software and post-acquisition
analysis conducted on FlowJo.
Human Serum Collection and Analysis
Human samples were collected on approval from the Ethics Committee of the National
Institute for Respiratory Diseases, KwaZulu-Natal Research Institute for TB and HIV, Durban,
South Africa; and The American British Cowdray Medical Center, Mexico City, Mexico on a
protocol approved by the Ethics Committee of the National Institute for Respiratory Diseases
(INER), KwaZulu-Natal Research Institute for TB and HIV (Currently renamed AHRI), South
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Africa and The American British Cowdray Medical Center. All subjects were of similar
socioeconomic status and unrelated to the third generation as determined by a questionnaire. TB
cases had symptoms (weight loss >10 kg, cough, fever, night sweats for >1 month, or cervical or
axillary lymphadenopathy) and chest radiographic findings consistent with recent pulmonary TB,
a positive sputum acid-fast smear and culture confirmed for Mtb. Fresh blood samples from
active pulmonary TB patients were obtained from patients recruited to the Tuberculosis
Outpatient Clinic, INER, Mexico, or the KwaZulu-Natal Research Institute for TB and HIV,
South Africa. Serum samples from all patients with active TB were collected prior to anti-Mtb
treatment and did not present comorbidities such as diabetes, HIV, cancer, and COPD. LTBI
patients were defined as asymptomatic individuals who had positive IGRA test results as
previously described.191 We simultaneously recruited a group of HCs and these individuals were
negative for IGRA tests at collection sites.
In Vitro Culture, Isolation, Stimulation, and Infection
Mouse lung epithelial cell line C10 cells were cultured to confluence in 24 well plates in
DMEM. Prior to in vitro infection hemocytometer counts from a representative well were used to
calculate multiplicity of infection (MOI). C10 cells were washed once with sterile PBS and then
infected with Mtb or Mtb mutant at an MOI of 1 in DMEM without antibiotics and incubated at
37°C, 7.5% CO2. Supernatants from the infection was collected and stored at −80°C. Cells were
collected by tryspinization and stained as per manufacturer's protocol.
Primary B6 mouse BMDMs and BMDCs were prepared as previously described.113
Briefly, bone marrow was harvested in a solution of serum free DMEM and then passed through
a 70 μm screen, spun down and then resuspended in red blood cell lysis solution. Equal volume
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of cDMEM was added and again spun down. The single cell suspension was plated at 1 × 106
cells per ml and supplemented with 4% GM-CSF for 7 days. At harvest, adherent cells were
collected as BMDMs, and floating cells were collected as BMDCs, gently washed with CDMEM
via centrifugation (1,200 rpm, 6 min at 4°C), resuspended and then plated at 1 × 106 cells per ml.
Indicated cell types were stimulated with either DATs resuspended in DMSO, or BSAcontrol or DAT-coated beads suspended in PBS as indicated at 200 μg/mL. Briefly, beads (1.5 ×
109 Polybead polystyrene beads) were washed twice in 0.05 M carbonate-bicarbonate buffer (pH
9.6) and then incubated with 50 μg of DATs or buffer alone for 1 h at 37°C. Beads were then
blocked with 5% BSA, washed repeatedly in 0.5% BSA, and finally adjusted to 4.0 × 108/ml in
0.5% BSA before being used. 388
Lipid Extraction and Analysis
Mtb bacterial pellets normalized by bacterial numbers (counted by microscopy, 1 × 1010)
were extracted with chloroform:methanol (2:1, v/v) following the previously published
method.358 Dried total lipids extracts were analyzed (loaded 100 μg by weight) by thin layer
chromatography using chloroform:methanol:water (90:10:1, v/v/v) as the mobile phase, and 10%
sulfuric acid in ethanol as a developer as described.381 Densitometry using NIH ImageJ software
was used to quantify all the spots/lipids per lane in each TLC, and to calculate the percentage of
total DATs and total PATs per lane. Densitometry analyses of each spot/lipids were also
calculated as using NIH ImageJ software (n = 3, where each value corresponds to independent
extractions and TLCs). DATs were purified by preparative TLC as previously described for other
Mtb cell envelope lipids,381 and used for in vitro studies at the indicated concentrations,
resuspended in DMSO.
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Statistical Analysis
Data analysis was conducted in GraphPad Prism 5 (La Jolla, CA) using unpaired two
tailed Student's t-test for comparison between two groups or one-way analysis of variance for
multiple comparisons. Significance is denoted as: *p < 0.05, **p < 0.01, ***p < 0.001, not
detected, ND.

4.4

Discussion and Conclusions
Although pulmonary Mtb infection is the leading cause of death by an infectious agent

worldwide, the initial steps in pathogenesis that govern the induction of iBALT formation within
granulomas remain unknown. In this study, using a transposon library in the NHP pulmonary
infection model, we have identified Mtb drivers of B cell-containing iBALT formation. Our
work here demonstrates that murine infection with the Δmmpl7 mutant induces increased iBALT
formation by dampening early innate immune responses. The Δmmpl7 mutant overexpressed
DATs in the cell wall, which drove abrogated inflammatory molecule production and increased
IL-10 in the lung, thus leading to decreased cellular recruitment. This study provides novel
evidence for a critical role for Mtb specific factors in skewing the earliest host pathogen
interactions that drive protective or detrimental disease outcomes.
Although significant advances have been made in understanding the factors that aid in the
intracellular survival of Mtb and their potential as therapeutic targets using in vitro approaches
and the mouse model, it is unclear if these factors play important roles in human tubercle
formation. Furthermore, most physiological events cannot be modeled by targeting a single gene
or its substrates, as interaction and/or compensation among several genes/pathways underpin
complex outcomes. Thus, in this study we have examined the Mtb determinants that mediate
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granulomas by using the well-established preclinical model of NHP TB infection. The macaque
model replicates many facets of clinically observed Mtb infection, thus providing relevance to
identification of Mtb determinants that drive or limit granuloma and iBALT formation. By
infecting NHPs with an Mtb mutant transposon library we have identified a novel subset of Mtb
genes associated with protective iBALT containing granulomas that correspond with effective
Mtb control. Although the gene subsets identified using this approach did not fall into any
specific pathway, they were interrelated in that they were predominantly involved in
mycobacterial growth and survival via responses to stress (Acr2, ClpB, Gln4, NdhA, and Cmtr)
or the synthesis/translocation of virulence components including lipids and proteins (Mmpl2,
Mmpl7, EccD5).
Among the two heat stress molecular chaperones identified in our study ClpB has already
been established as essential for the in vitro growth of Mtb,365 however the importance of Acr2 is
yet to be established. Acr2 is the most up-regulated gene following phagocytosis of Mtb by
macrophages365,382 and is under the control of the master regulator PhoP.383 Wilkinson et al.
found that Acr2 was strongly expressed in response to heat shock protein (HSP) Rv0251c and
appears to play a role in early immune responses.384 HSPs assist in Mtb survival but also act as
signaling agents to the host inflammatory mechanisms. While the role of Acr2 in Mtb virulence
in humans is not clear, it remains essential for virulence in a murine model of TB.384 To our
knowledge this is the first study to report on the association of absence of Acr2 with protective
granulomas in the NHP model.
Until recently NdhA was considered a non-essential protein found in the inner
mycobacterial membrane associated with nicotinamide adenine dinucleotide (NADH) mediated
electron transfer to the electron transport chain.363 Recent studies by Vilcheze et al. concluded
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that when NdhA is the only type I NADH dehydrogenase present in Mtb it affects Mtb growth
and renders it susceptible to oxidative stress.385 Likewise, while GlnA2 and GlnA4 are not
associated with Mtb virulence in vivo another member of this family GlnA1 was found to
contribute to Mtb virulence in a guinea pig model.386 Also, while a direct role for Cmtr in Mtb
virulence is yet to be established, a transcriptional survey of intracellular mycobacteria and their
host macrophages revealed signatures of heavy metal poisoning and an associated strong
induction of Cmtr and Csor which are known to encode metal responsive transcriptional
regulators.387
The Mtb cell wall expresses a variety of virulence factors that contribute to bacterial
survival and intrinsic drug resistance. Identification of genes that regulate uptake and secretion
machinery across the membrane is critical to characterizing the corresponding secretory products
and thus the pathogenesis of Mtb. EccD5 has been identified as being associated with protective
granulomas. EccD5 as part of the ESX-5 system is involved in the translocation of ProlineProline Glutamate (PPE) proteins and its disruption affects cell wall integrity leading to strong
attenuation of the pathogen in a mouse model.364 But the impact of EccD5 in human Mtb
infection or in NHPs is not known. Lastly, we also identified Mmpl2 and Mmpl7 to be associated
with protective granulomas in the NHP model. Sequencing of the Mtb genome revealed 12
membrane proteins that were primarily involved in transport of Mtb lipids. Mmpl-mediated lipid
secretion impacts both the innate ability of the pathogen to survive intracellularly and also the
host-pathogen interactions that determine the disease outcome. It has been previously established
that only Mmpl4 and the well-characterized Mmpl7, which transports PDIM to the MOM, have
both impaired growth kinetics and impaired lethality.388 In summary, our Mtb mutant transposon
library infection model in the NHPs has identified for the first time several unique Mtb genes
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whose roles in Mtb virulence were previously considered as redundant.
Since Mmpl7 is the most well-characterized of all Mmpl genes being the known
transporter of the virulence lipid PDIM, and as the substrate for Mmpl2 is currently not
known,389 we decided to focus our further studies utilizing the Mmpl7 mutant strain (Δmmpl7).
Beyond reduced expression of PDIM, the Δmmpl7 mutant also has an established in vivo growth
defect in the lung, spleen, and liver of mice, which we compensated for in our study by infecting
with higher doses of the mutant compared to wild type. The decreased CFU in the lungs of
Δmmpl7 mutant infected mice that we observed is similar to previous findings by Cox et al. and
others,390 but the decreased dissemination to the spleen was not previously observed. This is
likely due to the use of different background Mtb strains and routes of infection in our study.
Furthermore, our higher dose aerosol infection recapitulates a similar phenotype in increased
iBALT formation as the standard low dose aerosol infection. Thus, our findings suggest that the
improved TB disease outcomes observed is likely not simply due to the absence of PDIMs or a
growth defect of the mutant, but that the observed increased iBALT formation is likely driven
specifically by the Δmmpl7 mutant and overexpression of DATs.
Despite using a higher dose of the Δmmpl7 mutant in our infection studies, we observed
enhanced iBALT formation and abrogated inflammatory molecule production and cellular
recruitment, including both myeloid and lymphoid cell types. As T-cells are required for the
formation of iBALT, it would seem that slightly decreased T cell accumulation should also yield
decreased iBALT, which was not the case. However, our main observed differences in cellular
recruitment involved decreased early neutrophil associated responses, specifically abrogated
cytokines like IL-6 and G-CSF, and increased IL-10. It is known that neutrophils are
overrepresented in non-protective, necrotic granulomas that do not control or contain Mtb, and
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that neutrophil counts in peripheral blood, as well as IL-6 levels, correlate with ATB
disease.191,370,371
Our study confirms these findings with heightened blood levels of G-CSF in people with
active TB when compared to LTBI, and as such we used these two inflammatory cytokines as
readouts for response severity for our in vitro experiments. Thus, these data suggest that a lack of
IL-6 and G-CSF and decreased neutrophils may be skewing toward a dampened immune
response, potentially mediated by increased early IL-10, that allows for the enhanced formation
of iBALT containing granulomas as opposed to necrotic, neutrophil containing lesions. This
hypothesis is also supported by our findings in vitro, which show decreased IL-6 and G-CSF in
lung epithelial cells, a key source of inflammatory molecules, after Δmmpl7 mutant infection.
Importantly, we observed increased IL-10 production in macrophages and DCs after
Δmmpl7 mutant infection. It is known that IL-10 antagonizes IL-17 production, and thus
downstream G-CSF production,64 suggesting a potential mechanism for our observed dampened
immune responses and improved outcomes. Indeed, Mtb is capable of dampening immune
responses mediated by PRRs, and not just stimulating heightened inflammatory responses by
interactions with these receptors.
Mmpl7 is colocalized with genes involved in polyketide biosynthesis (pks genes) and
genes involved in lipid metabolism (PapA, FadD) suggesting that it is involved in complex lipid
transport involving more than one substrate in Mtb.391,392 Therefore, we aimed to determine if
there were any other differences in the lipid profile of Mtb beyond the loss of PDIM that could
explain the observed abrogated cytokine responses in vivo and in vitro. We found that DATs are
overrepresented in the Δmmpl7 mutant, validated by both 1D and 2D thin layer chromatography
(TLC). Mmpl10 is considered to be the putative agent responsible for the transport of DAT
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across the plasma membrane.389 Hence, it is likely that the absence of Mmpl7 during infection
could be compensated by Mmpl10 function accounting for the observed accumulation of DATs.
The addition of DATs during WT Mtb infection recapitulated our findings of decreased
inflammatory cytokine production in epithelial cells and yielded increased IL-10 production by
macrophages, both supporting what was observed in Δmmpl7 mutant infection in vivo. These
findings suggest distinct mechanisms for driving dampened immune responses depending on cell
types, with likely interactions of IL-10 sourced from macrophages driving decreased production
of inflammatory cytokines by epithelial cells. DATs likely do not act in isolation, as addition of
DATs to WT Mtb Erdman infection did not fully recapitulate all aspects of Δmmpl7 mutant
infection in vitro in these model systems.
Mycobacterial lipid virulence factors such as PDIMs are known to mask PAMPs and the
resultant downstream PRR signaling.268 Lipid virulence factors are also known to directly act as
TLR antagonists.393 Apart from TLRs, other surface receptors including Mincle, that recognizes
trehalose moieties,262-264 are likely involved in this phenomenon as BMDMs from Mincle
deficient mice reportedly produce less G-CSF and TNF in response to Mtb infection.394
Moreover, the expression of TLRs is also known to vary between different phagocytic cell
types.245 Hence these separate responses are likely due to differences in PRR expression and
signaling by these cell types. Interestingly, previous studies have shown DAT dependent
abrogation of inflammatory cytokine production in monocytes and macrophages in vitro.265 This
study was performed using several different human phagocyte models without abrogating the
expression of Mincle. While Mincle is established to interact with trehalose moieties, this study
validates our claim that DATs can drive abrogated inflammatory cytokine production,
independent of any manipulation of the expression of Mincle, suggesting a separate mechanism.
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It is likely that the interactions and modulated cytokine/chemokine production we have observed
involves other PRRs and Mtb lipid factors, beyond the singular interaction between DATs and
Mincle.264
While the various immune cells and cytokine/chemokine signals that contribute to
iBALT formation are well-established in a variety of disease contexts,51 the Mtb specific factors
that drive these protective responses, and the mechanism of those interactions, are poorly
understood. This study demonstrates that a single Mtb specific lipid factor can differentially
affect the ability of various cell types to produce inflammatory and anti-inflammatory cytokines,
all of which contribute in different aspects to the milieu that fosters conditions beneficial to
iBALT formation. In the context of an immune structure as complex as iBALT, where multiple
coordinated and regulated signals and cell types are required, future work will likely need to use
a similar approach across several in vivo and in vitro model systems examining multiple cell
types in order to elucidate the concise contribution of a specific Mtb factor and PRR interactions.
Future work may also need to examine not only multiple cell types, but also locational and
temporal cellular interactions throughout the course of infection, as a single Mtb factor is likely
neither necessary nor sufficient in isolation to drive iBALT by interactions with a single cell type
at one specific time point.
While this study was not exhaustive in analyzing all potential lipid factors involved, it
provides a framework for determining the contributions of the other Mtb genes and potential
candidate lipids in skewing toward protective outcomes. We acknowledge that the role of any
specific lipid in skewing iBALT formation is not an isolated phenomenon, as Mtb mutants
knocking out certain lipids inevitably drive compensatory overexpression of others. Furthermore,
we expect that the increased iBALT formation we have observed is likely due to a combination
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of a lack of PDIM along with increased DATs, with the possibility of other lipids being involved
that we did not identify or assay for.
Our novel findings demonstrate that genes associated with Mtb cell wall lipids are critical
to the initial interactions between Mtb and the host and suggest that Mtb specific lipids are key
determinants of the early immune response that skews toward formation of iBALT. Our findings
further provide a list of Mtb gene candidates for future work examining conditions needed for
protective iBALT formation, specifically aimed at early responses that determine these
outcomes. We have also demonstrated for the first time a panel of novel Mtb genes that are
associated with enhanced formation of protective iBALT containing granulomas and improved
disease outcomes, while most work on this topic examines genes involved in detrimental host
outcomes and loss of protection. This study thus provides a framework for future attenuated
vaccine candidates and mechanistic studies across model systems.
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Chapter 5: Perspectives and Conclusions
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5.1

Discussion and Future Directions

My doctoral dissertation work focuses on early innate immunity during pulmonary Mtb
infection, specifically in characterizing the contribution of lung resident AMs to both early
inflammatory responses and long-term disease outcomes. These connections between innate and
adaptive immunity are generally attributed to DCs, though my work demonstrates that AMs play
crucial roles in cytokine production, immune cell recruitment, granuloma and iBALT formation.
My studies focused on how AM specific signaling and effector functions were altered by Mtb
strains and cellular location within the lung, and further examined the implications these
modulations had on broader disease phenotypes during both early and later Mtb infection.
Another major goal of this work aimed to characterize how Mtb cell wall lipids can directly
modulate macrophage behavior and effector functions. Several cell wall lipids were studied in
this body of work and were found to have divergent effects on protective immunity in a variety
of contexts. These key interactions have durable effects on immune responses, and further
elucidating how to target both AM effector functions and Mtb specific lipids for advantageous
host responses remains a subject of ongoing study.

Lipid factors that modulate early immunity

Mtb strains and specific lipid factors drive critical interactions that modulate cytokine and
chemokine production by host cells, thus skewing the fundamental type of immune response
generated.23,64 Furthermore, Mtb specific determinants can alter host cell effector functions, as
we observed in multiple studies. For example, in Aim 1 we observed Mtb strain specific
induction of the CCR2:CCL2 axis during hypervirulent Mtb HN878 infection, and this drove the
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novel AM migration phenotype from the airways we reported.113 We found that CCR2 was
required for AM migration from the airways into granulomas in response to a specific induction
of CCL2 within and around granulomas. Interestingly, we show that susceptibility of CCR2-/mice to hypervirulent HN878 is not entirely due to expression of PGLs, a Mtb lipid factor known
to induce and exploit CCL2 production.144,145 We found that CCR2-/- mice were even more
susceptible to an HN878 pks gene mutant when compared to wildtype HN878, suggesting that
other lipid factors are at play that make HN878 potentially even more inflammatory in the
absence of the PKS gene family. As previously discussed, many Mtb lipid virulence factors are
regulated by PKS genes, and the compensatory mechanism of hyperinflammation we observed
could be due to one or multiple of these candidates. In future work we will examine how the
known and unknown lipid targets of PKS genes are involved in hypervirulence and driving overt
inflammation.
In both Aims 1 & 3, we also show that alteration of Mtb lipid factor, such as PGLs,
DATs, and PDIM, can have effects on formation of granulomas and iBALT. We observed that
overexpression of DATs, as a compensatory mechanism for decreased expression of PDIM on
the MOM, drove dampened inflammatory responses in macrophages and epithelial cells that
improved iBALT formation and overall disease outcomes.192 We furthermore provide a
framework for examining the contribution of individual lipids to these processes, which can be
applied to other Mtb mutants and lipid virulence factors of interest. These findings suggest that
future research should involve comparison of multiple Mtb strains in order to properly examine
any cellular mechanism or host disease phenotype. Furthermore, a robust database to compare
the lipidome of various catalogued Mtb strains would be a useful reference tool for researchers,
allowing specific phenotypes and mechanisms to be properly attributed to specific Mtb lipid
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factor interactions with host determinants. Significantly, determining the concise contribution of
specific Mtb lipid factors such as PGLs, PDIM, and DATs examined in my work, will pave the
way for use of these lipids as components or adjuvants in future vaccine formulations, or
potential targets for Mtb neutralization strategies.
While my studies did not cover this topic, another key facet of future work should
examine how host cell metabolism is affected by Mtb lipids. Characterizing how functional roles
of immune cell types are directly affected by the presence or absence of individual Mtb lipids
would provide specific targets for future therapeutic strategies aimed at either neutralizing Mtb
lipids or inducing/abrogating specific cellular effector functions. Specifically driving beneficial
cellular processes while inhibiting damaging or detrimental processes would allow for more
rapid clearing of infection with less damaging inflammation. Similarly, host directed therapeutic
strategies do not run the same risk of developing resistance as antibiotic courses do,
demonstrating an attractive alternative to the current standard of care.

Host factors and signaling that drive AM compartmental migration and effector function

In my previous work, we correlated AM migration from the airway to the formation of
protective granuloma structures, but the contributions of specific cytokines and chemokines
beyond the CCR2 axis were not examined. It is likely that, similar to migration phenotypes
previously observed in T-cells, that multiple chemokine axes contribute to AM migration into
granulomas. It is also likely that distinct chemokine axes are involved in airway homing of
neutrophils and other inflammatory cells, so a concise, targeted approach at inducing or
abrogating cellular migration will be challenging.
AMs do not perform their effector functions in a vacuum; therefore mDCs, neutrophils,
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T-cells, and lung epithelial cells were also examined in my studies, though not to the same depth
and extent. Future work will characterize concise interactions between AMs and these other cell
types individually, specifically using co-culture approaches and targeted genetic manipulation to
characterize beneficial components. Understanding the bystander cell specific factors that drive
the differential AM effector functions will allow us to characterize additional correlates of
protection against Mtb. It is known that epithelial cells and AMs drive mutual signal
amplification during Mtb infection, inducing production of inflammatory cytokines that then in
turn further activate neighboring cells.33 This key early interaction likely drives the phenotypes
we have observed across my studies, and determining the specific contributions of PRRs,
cytokines, and Mtb specific factors to AM priming and activation will be a general theme of
applied future work.

Targeting M1 polarization as a tool for priming innate immunity

From our RNA-seq data presented in Chapter 2, we observed that many of the
differentially expressed genes and pathways upregulated in the non-airway AMs were mediated
by NF-κB. This suggested a key signaling target to further parse out the previously unknown
non-airway phenotype of AMs. Furthermore, NF-κB and the subunit Iκκ2 are considered critical
to Mtb immune responses, though activation of this nexus drives overt, damaging inflammation
that is detrimental to the host. Concurrent studies recapitulated our AM migration phenotype,
and demonstrated a dependence on IL-1β/IL1R signaling and the inflammasome for this
function.126 Furthermore, other work has demonstrated compartmentally distinct functions for
lung macrophages, though identification of specific macrophage subsets was less robust.67,109
Taken together, these studies support a link between M1 polarization, NF-κB signaling, and the
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IL-1β/inflammasome pathway in driving compartmentally distinct functions for AMs
In future work, we will further examine the AM specific requirements for driving
compartmental migration of AMs, and determine if this function is advantageous for therapeutic
targeting. Future studies will characterize AM specific genes and specific cellular interactions
and/or cytokine/chemokine signals required for migration to granulomas, coordinating
inflammation, and Mtb killing. Considering several of these pathways have been rigorously
studied in a variety of contexts for decades, robust genetic models and effective drugs can be
used to specifically examine the contribution of individual axes in the protective or detrimental
mechanisms at play. If migration of M1 polarized AMs into granulomas is indeed protective,
targeting this functionality to therapeutically induce interstitial localization could be a major
milestone in utilizing early clearance to combat pulmonary Mtb infection.

5.2

Closing Remarks

Taken together, my dissertation research demonstrates the consequential role of early
innate immunity in determining host outcomes to pulmonary Mtb infection. We examine specific
factors involved in the earliest interactions between Mtb and the host, and present evidence that
these early interactions have long term protective or detrimental consequences for disease
outcomes. These studies together elucidate the earliest mechanisms of protective innate
immunity and shed new light on the critical primary interactions between macrophages, Mtb and
epithelial cells that drive short- and long-term disease outcomes in pulmonary TB.
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Supplementary Figure 1: The flow cytometry gating strategy for myeloid populations, validated with additional
surface markers. (a) Briefly, AMs were defined as CD11b- CD11c+ Siglec F+ ; > 90% of these AMs also express
CD64+ . Neutrophils were defined as CD11b+ CD11c-Gr-1hi cells; neutrophils also express Ly6G, but not Ly6C.
Monocytes were defined as CD11b+ CD11c-Gr-1lo cells; the majority of them expressed Ly6C and CX3CR1. RMs
were defined as CD11b+ CD11c-Gr-1- ; RMs also expressed CX3CR1, but not CD64 or Ly6C. Red boxes define the
criteria used for gating subsets in all figures.
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Supplementary Figure 2: Accumulation of lung innate and adaptive cell populations upon H37Rv or HN878
infection in B6 and CCR2-/- mice. (a-e) B6 and CCR2-/- mice (n=5) were aerosol-infected with 100 CFU of H37Rv
and lung innate immune populations were determined at 30 d.p.i. by flow cytometry. (f-h) B6 and CCR2-/- mice were
infected with H37Rv or HN878 and accumulation of total CD4+ T cells and CD44hi activated CD4+ T cells producing
IFN-γ were determined using flow cytometry. Un.=uninfected, Monos=Monocytes, AMs=Alveolar Macrophages,
RMs=Recruited Macrophages, mDCs=Myeloid Dendritic Cells, Neuts=Neutrophils. n=5, (a-h) 1-Way ANOVA with
Tukey’s post-test.
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Supplementary Figure 3: CCL2 deficient mice are susceptible to HN878 infection. (a) B6 and CCL2-/- (n=5) were
infected with HN878 and lung bacterial burden was analyzed at 30 d.p.i. (b) Chemokines protein levels were measured
in lung homogenates of HN878 infected IKK2fl/fl Sftpc-Cre mice and littermate controls at 21 d.p.i. (a-b) Student’s ttest.
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Supplementary Figure 4: Validation of airway labeling technique using the HCl lung injury model. B6 mice
were treated i.t. with 50 uL of sterile water (vehicle, n=4) or HCl (pH 1.5, n=5) and rested 24 hours prior to airway
CD45.2 labelling and lung harvest. (a) The percentage of total lung cells stained with airway CD45.2 was determined
by flow cytometry. (b) Total cell counts for lung myeloid populations were determined by flow cytometry. (c) The
percentage of each myeloid cell type positive for airway labelled CD45.2 in vehicle and HCl treated mice is shown.
(d) Airway label CD45.2 PE localization was by IHC in PBS treated and HCl treated mice. (e) BAL samples were
collected ~10 min after airway labelling with CD45.2 Ab from uninfected and infected mice at 45 d.p.i. The proportion
of AMs stained with airway CD45.2 (left panel, uninfected average= 98.6%, infected =97.5%) as well as the
proportion of AMs of the total collected BAL sample (right panel, uninfected average= 48.6%, infected=15.3%). (ad) Student’s t-test was used to compare between groups separately for each myeloid cell type. (e) Student’s t-test.
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Supplementary Figure 5: Sorting strategy of airway AMs and non-airway AMs. Single cell lung suspensions
from airway CD45.2 labelled, uninfected (n=4) and infected mice (n=4-5) were prepared and (a) the gating strategy
for airway and non-airway AMs is shown. Briefly, CD11c+ SiglecF+ CD45.2+ cells were gated as airway AMs, while
CD11c+ SiglecF+ CD45.2- cells were gated as non-airway AMs. (b) Enrichment of AMs by CD11c magnetic bead
sorting for adoptive transfer into mice was carried out using the Miltenyi CD11c+ sorting kit. Expression of SiglecF
and CD11c on sorted cells was determined by flow cytometry.
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Supplemental Figure 6: Δmmpl7 mutant drives Mtb enhanced B cell follicle formation in mouse model. Sex and
age matched C57BL/6 mice were infected with 100 CFU of Mtb Erdman WT or 500 CFU Δmmpl7. A) Lung
homogenates were taken and serially diluted to determine bacterial CFU counts at indicated time points. B) Lungs
from Mtb-infected mice at 40 d.p.i. were formalin fixed, embedded in paraffin and used for H&E staining and
inflammation was quantified by tracing areas. C) B-cell follicles present within lung sections were visualized by
confocal microscopy. Slides were visualized and quantified by outlining the lesions using the automated tool of the
Zeiss Axioplan 2 microscope. Infected groups (n≥5) comparing WT Erdman and Δmmpl7 Mtb strains at individual
time points were compared using Student’s t-test. Mean and standard deviation (SD) were plotted for each group at
each indicated time point. *p<0.05, **p<0.01, ***p<0.001
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Supplemental Figure 7: Δmmpl7 mutant Mtb overexpresses DATs. Two dimensional Thin Layer Chromatography
was performed on total lipids from Mtb Erdman WT or Δmmpl7 obtained as described in the main text and as resolved
using the following solvent systems: System A: (1) petroleum ether (boiling point 60–80 °C)/ethyl acetate (98 : 2,
three times); (2) petroleum ether/acetone (98 : 2). System B: (1) petroleum ether/acetone (92 : 8, three times); (2)
toluene/acetone (95 : 5). System C: (1st D) chloroform/methanol (96 : 4); (2nd D) toluene/acetone (80 : 20). System D:
(1) chloroform/methanol/water (100 : 14 : 0.8); (2) chloroform/acetone/methanol/water (50 : 60 : 2.5 : 3).System E:
(1) chloroform/methanol/water (60 : 30 : 6); (2) chloroform/acetic acid/methanol/water (40 : 25 : 3 : 6). Identities of
separated lipid moieties 1-2: Phthiocerol dimycocerosate (PDIM) family; 3: Triacylglycerides (TAG); 4-8:
Mycolipenates of Trehalose; 9: Free fatty acid (FA); 10-12: Unknown (?); 13: Phenolic Glycolipid-I (PGL-I); 14-15:

167

Mixture of Free Fatty Acids (FA) and Diacyl glycerols (DAGs)*; 16: Sulfolipid-I (SL-I); 17: Unknown (?)**; 18:
Glycolipid; 19-20: Sulfolipids (SL); 21: Trehalose Dimycolate (TDM); 22: Mixture of Diacyl trehaloses (DATs, black
arrows) and Trehalose Monomycolate (MMT); 23: Diphosphatidyl-Glycerol (DPG); 24: Ac2PIM2; 25-26:
Phospholipids (PC, PE, PS); 27: Ac1PIM2; 28: PI; 29: Ac2PIM6; 30: Ac1PIM6; 31-32: Lipooligosaccharides (LOSs).
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Supplemental Figure 8: DAT administration does not significantly alter apoptosis and cell death in epithelial
cells, macrophages, or DCs. A) Mouse lung epithelial cells (n=5) were treated with either 2.5% DMSO or raw DATs
in DMSO at indicated dosage for 6 days. B) Mouse bone marrow derived Macrophages (BMDMs) (n=5) or C)
dendritic cells (BMDCs) (n=5) were infected with Mtb Erdman WT with or without the addition of BSA control or
DAT coated agarose beads, or Δmmpl7 for 3 days. The percentage of live (left panels; Annexin V-, 7-AAD-), apoptotic
(middle panels; Annexin V+, 7-AAD-), and dead (right panels; Annexin V+, 7-AAD+) cells were quantified by flow
cytometry utilizing Annexin V and 7-AAD staining as per manufacturer’s suggested protocol. Multiple groups were
compared by 1-way ANOVA with Tukey’s post-tests. *p<0.05, **p<0.01, ***p<0.001. Mean and standard deviation
(SD) were plotted for each group at each indicated time point.
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Supplementary Table 1: Gene expression values of airway and non-airway AM transcriptional signatures from
Mtb-infected mice. RNA sequencing datasets of populations of sorted airway (CD45.2+ CD11c+ SiglecF+ ) and nonairway AMs (CD45.2- CD11c+ SiglecF+ ) from infected (n=4-5, 100 CFU HN878, 30 d.p.i.) and uninfected mice (n=4)
were analyzed for expression (Log FPKM) of the common AM gene signature (Gautier et al 2012, Misharin et al
2017) (i.e. Siglecf, Pparg, Tgfbr2, Csf2r, Mertk, Itgax, Lyz2, Sftpc,, and Fcgr1) and genes associated with monocytederived interstitial or recruited macrophages (i.e. Ly6c1, Itgam, Cx3cr1, and CD163).
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Supplementary Table 2: Pearson correlation of gene expression levels between sorted airway and non-airway
AMs from infected mice. RNA sequencing datasets of populations of sorted airway (CD45.2+ CD11c+ SiglecF+ ) and
non-airway AMs (CD45.2- CD11c+ SiglecF+ ) from infected (n=4-5, 100 CFU HN878, 30 d.p.i.) and uninfected mice
(n=4) were compared by Pearson correlation for expression of all genes (a) and the AM signature genes (b).
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Supplementary Table 4: KEGG pathways significantly enriched among the 116 genes overexpressed in nonairway AMs compared to airway AMs during infection. Differentially expressed genes overexpressed in nonairway samples were tested for significant enrichment among KEGG pathways using WebGestalt (default settings,
adjusted P = 0.05 threshold for enrichment).

Supplementary Table 5: Descriptions of the 12 genes significantly overexpressed in airway AMs compared to
non-airway AMs in HN878-infected mice. RNA-sequencing of sorted airway AMs (CD45.2+ CD11c+SiglecF+ ) and
non-airway AMs (CD45.2- CD11c+ SiglecF+) from HN878 infected B6 mice (n=4-5) at 30 d.p.i. DESeq2 was used to
determine overexpressed genes compared to non-airway samples. FPKM average expression levels and adjusted p
values displayed for each.

Supplementary Tables 3, 6, 7: See Dunlap et al, 2018 for large data sets
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